"ChEMBL ID";"Assay Type";"Description";"Organism";"Compounds";"Activities";"BAO Format ID";"BAO Format";"Confidence Score";"Confidence Label";"Strain";"Source";"Tax ID";"Tissue ChEMBL ID";"Tissue Name";"Cell Type";"Subcellular Fraction";"Document ChEMBL ID";"PubMed ID";"DOI";"Year";"Journal";"Volume";"First Page";"Last Page";"Assay Parameters";"Assay Classification L1";"Assay Classification L2";"Assay Classification L3";"Variant Sequence Accession";"Variant Sequence Mutation"
"CHEMBL1908760";"B";"Binding constant for PLK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1051316";"B";"Binding constant for full-length TSSK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1037553";"B";"Binding constant for MERTK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908508";"B";"Binding constant for PAK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908414";"B";"Binding constant for JNK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908660";"B";"Binding constant for LATS1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908706";"B";"Binding constant for EPHA3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908738";"B";"Binding constant for PIK3CA(H1047L) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P42336";"H1047L"
"CHEMBL1908599";"B";"Binding constant for MEK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908670";"B";"Binding constant for JAK2(JH1domain-catalytic) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908684";"B";"Binding constant for ABL1(Q252H)-phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"Q252H"
"CHEMBL1908510";"B";"Binding constant for MINK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908572";"B";"Binding constant for PDGFRB kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908589";"B";"Binding constant for p38-delta kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908624";"B";"Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908828";"B";"Binding constant for FGFR2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908453";"B";"Binding constant for MAP4K4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908455";"B";"Binding constant for RIPK5 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908650";"B";"Binding constant for EPHA7 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908756";"B";"Binding constant for YSK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908806";"B";"Binding constant for BIKE kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908837";"B";"Binding constant for MARK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908432";"B";"Binding constant for ANKK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908820";"B";"Binding constant for RET(V804L) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P07949";"V804L"
"CHEMBL1061899";"B";"Binding constant for FYN kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063716";"B";"Binding constant for MLK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061177";"B";"Binding constant for MLK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051339";"B";"Binding constant for MUSK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051255";"B";"Binding constant for PRKCQ kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062838";"B";"Binding constant for CIT kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061140";"B";"Binding constant for CLK4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063702";"B";"Binding constant for CSF1R kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060186";"B";"Binding constant for CSNK1G1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060187";"B";"Binding constant for DAPK3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060192";"B";"Binding constant for EPHB4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060259";"B";"Binding constant for MYO3B kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060252";"B";"Binding constant for NDR2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1037544";"B";"Binding constant for LYN kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060245";"B";"Binding constant for ERK4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062859";"B";"Binding constant for PRKG1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908759";"B";"Binding constant for MAP3K2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908752";"B";"Binding constant for MST1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908545";"B";"Binding constant for CSNK2A1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1060234";"B";"Binding constant for ACVR2A kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1057608";"B";"Binding constant for ACVR2B kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908566";"B";"Binding constant for NEK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908567";"B";"Binding constant for NEK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908588";"B";"Binding constant for JNK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908419";"B";"Binding constant for MKK7 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908477";"B";"Binding constant for CDK4-cyclinD1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908481";"B";"Binding constant for INSR kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908533";"B";"Binding constant for IKK-beta kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908540";"B";"Binding constant for CAMK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908548";"B";"Binding constant for ERBB3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908560";"B";"Binding constant for MARK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908604";"B";"Binding constant for SYK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908446";"B";"Binding constant for CASK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1787525";"B";"Binding affinity to human KIT incubated for 1 hr by kinase binding assay";"Homo sapiens";"39";"39";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1782045";"21429632";"10.1016/j.ejmech.2011.02.057";"2011";"Eur J Med Chem";"46";"2043";"2057";"";"";"";"";"";""
"CHEMBL1051277";"B";"Binding constant for ABL1(T315I) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P00519";"T315I"
"CHEMBL1062842";"B";"Binding constant for IRAK3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063713";"B";"Binding constant for JNK3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061076";"B";"Binding constant for full-length JNK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1037546";"B";"Binding constant for AAK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908663";"B";"Binding constant for DCAMKL1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908798";"B";"Binding constant for TAOK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1063729";"B";"Binding constant for FLT3(ITD) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908827";"B";"Binding constant for FGFR4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908411";"B";"Binding constant for p38-alpha kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908440";"B";"Binding constant for LTK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908689";"B";"Binding constant for ABL1-phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908774";"B";"Binding constant for DAPK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908790";"B";"Binding constant for TNIK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908804";"B";"Binding constant for DMPK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908829";"B";"Binding constant for FGFR1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908413";"B";"Binding constant for CSNK1D kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908721";"B";"Binding constant for PRKD3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908737";"B";"Binding constant for PIK3CA(E545K) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P42336";"E545K"
"CHEMBL1908609";"B";"Binding constant for TYK2(JH1domain-catalytic) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1039275";"B";"Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051263";"B";"Binding constant for YSK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051317";"B";"Binding constant for ZAK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908539";"B";"Binding constant for BMX kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908511";"B";"Binding constant for DCAMKL2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908515";"B";"Binding constant for ULK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908516";"B";"Binding constant for ACVR1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908564";"B";"Binding constant for MLK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908583";"B";"Binding constant for ERK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908618";"B";"Binding constant for MAP4K3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908652";"B";"Binding constant for EPHB3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908680";"B";"Binding constant for ABL1(H396P)-non phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"H396P"
"CHEMBL1908449";"B";"Binding constant for SNRK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908810";"B";"Binding constant for MARK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1063790";"B";"Binding constant for ACVRL1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908435";"B";"Binding constant for MLCK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908718";"B";"Binding constant for LIMK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908653";"B";"Binding constant for EPHB4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908814";"B";"Binding constant for PAK7 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908834";"B";"Binding constant for MEK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908402";"B";"Binding constant for MYLK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908463";"B";"Binding constant for p38-gamma kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908524";"B";"Binding constant for CAMK2B kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908705";"B";"Binding constant for EPHA1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908654";"B";"Binding constant for EPHB6 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908799";"B";"Binding constant for PRKD2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908399";"B";"Binding constant for BRSK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908622";"B";"Binding constant for RIPK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908664";"B";"Binding constant for RPS6KA5(Kin.Dom.2-C-terminal) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908666";"B";"Binding constant for ROCK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908693";"B";"Binding constant for EGFR kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908723";"B";"Binding constant for MAP3K1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908742";"B";"Binding constant for PIK3CA(Q546K) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P42336";"Q546K"
"CHEMBL1908763";"B";"Binding constant for IRAK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908812";"B";"Binding constant for PAK6 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908830";"B";"Binding constant for CDC2L2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908409";"B";"Binding constant for DYRK1A kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908456";"B";"Binding constant for PFCDPK1(P.falciparum) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908464";"B";"Binding constant for MERTK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908472";"B";"Binding constant for STK16 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908507";"B";"Binding constant for GCN2(Kin.Dom.2,S808G) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"Q9P2K8";"S808G"
"CHEMBL1908526";"B";"Binding constant for CDK8 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908534";"B";"Binding constant for IRAK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908627";"B";"Binding constant for TNK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908641";"B";"Binding constant for ALK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908699";"B";"Binding constant for EGFR(L747-T751del,Sins) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908779";"B";"Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1050826";"B";"Binding constant for FLT3(D835Y) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P36888";"D835Y"
"CHEMBL1061071";"B";"Binding constant for FER kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051256";"B";"Binding constant for PRKG2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061928";"B";"Binding constant for full-length SRPK2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060182";"B";"Binding constant for EGFR kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051285";"B";"Binding constant for EGFR(L747-T751del,Sins) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051289";"B";"Binding constant for MEK6 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063792";"B";"Binding constant for CAMK2D kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1050825";"B";"Binding constant for DDR1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063706";"B";"Binding constant for DMPK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061069";"B";"Binding constant for EPHA5 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051337";"B";"Binding constant for LCK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051354";"B";"Binding constant for TGFBR2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908633";"B";"Binding constant for FLT3(D835Y) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P36888";"D835Y"
"CHEMBL1908538";"B";"Binding constant for BLK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908498";"B";"Binding constant for MAP3K15 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908458";"B";"Binding constant for CDC2L5 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1051304";"B";"Binding constant for PDGFRB kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051312";"B";"Binding constant for RIPK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1050831";"B";"Binding constant for PIK3CA(E545K) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P42336";"E545K"
"CHEMBL1908821";"B";"Binding constant for RET(V804M) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P07949";"V804M"
"CHEMBL1908838";"B";"Binding constant for RIOK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908484";"B";"Binding constant for KIT(A829P) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P10721";"A829P"
"CHEMBL1908490";"B";"Binding constant for KIT(V559D,V654A) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P10721";"V559D,V654A"
"CHEMBL1908576";"B";"Binding constant for PIK3CG kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908590";"B";"Binding constant for MEK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908621";"B";"Binding constant for RIPK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908632";"B";"Binding constant for FLT3(D835H) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P36888";"D835H"
"CHEMBL1908765";"B";"Binding constant for NEK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908427";"B";"Binding constant for CAMK2A kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908486";"B";"Binding constant for KIT(D816V) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P10721";"D816V"
"CHEMBL1908531";"B";"Binding constant for DAPK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908562";"B";"Binding constant for MAP3K3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908593";"B";"Binding constant for PRKR kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908595";"B";"Binding constant for GRK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908602";"B";"Binding constant for CDKL5 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908667";"B";"Binding constant for CDK5 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908778";"B";"Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908832";"B";"Binding constant for ADCK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908816";"B";"Binding constant for CAMK1G kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1244982";"B";"Binding affinity to SRC";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244506";"B";"Binding affinity to MEK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219022";"B";"Millipore: Percentage of residual kinase activity of DAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219075";"B";"Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219248";"B";"Millipore: Percentage of residual kinase activity of LCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219287";"B";"Millipore: Percentage of residual kinase activity of STK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218951";"B";"Millipore: Percentage of residual kinase activity of AURKB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218952";"B";"Millipore: Percentage of residual kinase activity of AURKC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244777";"B";"Binding affinity to CSNK1D";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244988";"B";"Binding affinity to STK33";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244568";"B";"Binding affinity to PIK3CA C420R mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P42336";"C420R"
"CHEMBL1244923";"B";"Binding affinity to PIM2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244741";"B";"Binding affinity to BRK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244703";"B";"Binding affinity to ABL1 E255K mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00519";"E255K"
"CHEMBL1244760";"B";"Binding affinity to CDK5";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244721";"B";"Binding affinity to AKT3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908513";"B";"Binding constant for HPK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1037551";"B";"Binding constant for full-length CDK5";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051350";"B";"Binding constant for full-length PFTK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061923";"B";"Binding constant for full-length PIP5K1A";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1056938";"B";"Binding constant for RPS6KA5(Kin.Dom.2 - N-terminal) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051352";"B";"Binding constant for SgK085 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244792";"B";"Binding affinity to DDR2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244488";"B";"Binding affinity to MAK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244943";"B";"Binding affinity to PRKG1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244975";"B";"Binding affinity to SBK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244998";"B";"Binding affinity to TEC";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244919";"B";"Binding affinity to PIK3CD";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244918";"B";"Binding affinity to PIK3CB";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244944";"B";"Binding affinity to PRKG2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908801";"B";"Binding constant for MYO3A kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908743";"B";"Binding constant for PIK3CB kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908431";"B";"Binding constant for YANK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908688";"B";"Binding constant for ABL1-non phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908728";"B";"Binding constant for MRCKB kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1062873";"B";"Binding constant for STK36 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061929";"B";"Binding constant for TEC kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908460";"B";"Binding constant for RIPK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908601";"B";"Binding constant for NEK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908639";"B";"Binding constant for DRAK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1062834";"B";"Binding constant for AURKB kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060237";"B";"Binding constant for AXL kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061138";"B";"Binding constant for full-length CDK2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908608";"B";"Binding constant for TXK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908787";"B";"Binding constant for ICK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908600";"B";"Binding constant for SRPK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908613";"B";"Binding constant for ULK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908617";"B";"Binding constant for MRCKA kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908696";"B";"Binding constant for EGFR(G719S) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00533";"G719S"
"CHEMBL1908776";"B";"Binding constant for NEK6 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908784";"B";"Binding constant for MELK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908803";"B";"Binding constant for MARK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908457";"B";"Binding constant for PFPK5(P.falciparum) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908403";"B";"Binding constant for MLK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908769";"B";"Binding constant for TBK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908468";"B";"Binding constant for TLK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908469";"B";"Binding constant for AURKB kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908473";"B";"Binding constant for PCTK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908549";"B";"Binding constant for FES kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908596";"B";"Binding constant for ROS1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908681";"B";"Binding constant for ABL1(H396P)-phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"H396P"
"CHEMBL1908713";"B";"Binding constant for SRC kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908755";"B";"Binding constant for VRK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908451";"B";"Binding constant for NEK7 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908480";"B";"Binding constant for FGFR3(G697C) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P22607";"G697C"
"CHEMBL1908543";"B";"Binding constant for CSNK1A1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908400";"B";"Binding constant for MAPKAPK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908439";"B";"Binding constant for NEK5 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908682";"B";"Binding constant for ABL1(M351T)-phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"M351T"
"CHEMBL1908687";"B";"Binding constant for ABL1(Y253F)-phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"Y253F"
"CHEMBL1908690";"B";"Binding constant for ABL2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908744";"B";"Binding constant for AMPK-alpha2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908777";"B";"Binding constant for EIF2AK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL2218969";"B";"Millipore: Percentage of residual kinase activity of CDK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1063714";"B";"Binding constant for full-length LIMK2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063804";"B";"Binding constant for full-length MKNK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061129";"B";"Binding constant for ABL1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2219135";"B";"Millipore: Percentage of residual kinase activity of PIM1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219404";"B";"Millipore: Percentage of residual kinase activity of PRKCG at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219382";"B";"Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219399";"B";"Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219115";"B";"Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219140";"B";"Millipore: Percentage of residual kinase activity of PIM3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.1% Triton X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219348";"B";"Millipore: Percentage of residual kinase activity of MTOR at 10uM relative to control. Control inhibitor: Rapamycin at 10.0uM. Buffer: 50 mM HEPES pH 7.5, 1 mM EGTA, 0.01% Tween 20, 10 uM FKBP12";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1061153";"B";"Binding constant for full-length PHKG1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2219176";"B";"Millipore: Percentage of residual kinase activity of MAPK12 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219178";"B";"Millipore: Percentage of residual kinase activity of MAPK13 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219328";"B";"Millipore: Percentage of residual kinase activity of WNK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218945";"B";"Millipore: Percentage of residual kinase activity of ABL1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1908726";"B";"Binding constant for BRK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908734";"B";"Binding constant for PIK3CA(C420R) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P42336";"C420R"
"CHEMBL1244815";"B";"Binding affinity to EPHA4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244498";"B";"Binding affinity to MAPKAPK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244804";"B";"Binding affinity to EGFR G719S mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00533";"G719S"
"CHEMBL1244848";"B";"Binding affinity to FLT3 ITD mutant";"";"7";"7";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244731";"B";"Binding affinity to AURKC";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244745";"B";"Binding affinity to CAMK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244754";"B";"Binding affinity to CAMKK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244757";"B";"Binding affinity to CDK11";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244508";"B";"Binding affinity to MEK4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244560";"B";"Binding affinity to PDPK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244955";"B";"Binding affinity to RIOK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244957";"B";"Binding affinity to RIOK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244747";"B";"Binding affinity to CAMK1G";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244748";"B";"Binding affinity to CAMK2A";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244761";"B";"Binding affinity to CDK7";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244774";"B";"Binding affinity to CSF1R";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244780";"B";"Binding affinity to CSNK1G2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244788";"B";"Binding affinity to DCAMKL1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244790";"B";"Binding affinity to DCAMKL3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244800";"B";"Binding affinity to DYRK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244853";"B";"Binding affinity to FYN";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908495";"B";"Binding constant for LKB1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1244474";"B";"Binding affinity to KIT L576P mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P10721";"L576P"
"CHEMBL1244475";"B";"Binding affinity to KIT V559D mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P10721";"V559D"
"CHEMBL1244491";"B";"Binding affinity to MAP3K2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244528";"B";"Binding affinity to MST4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244559";"B";"Binding affinity to PDGFRB";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908518";"B";"Binding constant for YANK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1244948";"B";"Binding affinity to PYK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245018";"B";"Binding affinity to TYRO3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244503";"B";"Binding affinity to MARK4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244556";"B";"Binding affinity to PCTK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244931";"B";"Binding affinity to PKN2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244972";"B";"Binding affinity to RPS6KA5(Kin.Dom.2-C-terminal)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245007";"B";"Binding affinity to TNK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244717";"B";"Binding affinity to ADCK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244768";"B";"Binding affinity to CHEK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908558";"B";"Binding constant for LIMK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1244803";"B";"Binding affinity to EGFR G719C mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00533";"G719C"
"CHEMBL1244828";"B";"Binding affinity to ERK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244459";"B";"Binding affinity to IKK-epsilon";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908452";"B";"Binding constant for ZAK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1245032";"A";"Cmax in nu/nu mouse at 10 mg/kg, po";"Mus musculus";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"standard_type:DOSE standard_relation:= standard_value:10.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL1245034";"A";"AUC (0 to 24 hrs) in nu/nu mouse at 10 mg/kg, po";"Mus musculus";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"CHEMBL3559721";"Plasma";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"standard_type:DOSE standard_relation:= standard_value:10.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL1244993";"B";"Binding affinity to TAK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244714";"B";"Binding affinity to ACVR2A";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244795";"B";"Binding affinity to DMPK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244468";"B";"Binding affinity to JH1 catalytic domain of JAK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244489";"B";"Binding affinity to MAP3K1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244494";"B";"Binding affinity to MAP4K2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908485";"B";"Binding constant for KIT(D816H) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P10721";"D816H"
"CHEMBL1908496";"B";"Binding constant for TIE2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908668";"B";"Binding constant for DAPK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908747";"B";"Binding constant for PKN2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908826";"B";"Binding constant for HIPK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908714";"B";"Binding constant for TIE1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908746";"B";"Binding constant for PRKCH kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908805";"B";"Binding constant for MKNK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL2219253";"B";"Millipore: Percentage of residual kinase activity of MAPK1 at 1uM relative to control. Control inhibitor: ERK Inhibitor II at 30.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219383";"B";"Millipore: Percentage of residual kinase activity of MAP3K5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1061157";"B";"Binding constant for full-length PRKX";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1050838";"B";"Binding constant for full-length CLK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2218992";"B";"Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1051315";"B";"Binding constant for TIE2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061984";"B";"Binding constant for TLK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061933";"B";"Binding constant for TRKA kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062875";"B";"Binding constant for TRKB kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1041998";"B";"Binding constant for TRKC kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244725";"B";"Binding affinity to ANKK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1062788";"B";"Binding constant for full-length TNK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062777";"B";"Binding constant for GAK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063710";"B";"Binding constant for ERK3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062868";"B";"Binding constant for RAF1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061179";"B";"Binding constant for RET kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244973";"B";"Binding affinity to RPS6KA6(Kin.Dom.1-N-terminal)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244925";"B";"Binding affinity to PIP5K1A";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244539";"B";"Binding affinity to NEK6";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244793";"B";"Binding affinity to DLK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244805";"B";"Binding affinity to EGFR L747-E749del, A750P mutant";"";"7";"7";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908544";"B";"Binding constant for CSNK1E kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908554";"B";"Binding constant for HCK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1245033";"A";"Tmax in nu/nu mouse at 10 mg/kg, po";"Mus musculus";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"standard_type:DOSE standard_relation:= standard_value:10.0 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL1244845";"B";"Binding affinity to FLT3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244515";"B";"Binding affinity to MINK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244933";"B";"Binding affinity to PLK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219145";"B";"Millipore: Percentage of residual kinase activity of PRKX at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244812";"B";"Binding affinity to EPHA1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2218944";"B";"Millipore: Percentage of residual kinase activity of ABL1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1245023";"B";"Binding affinity to WEE1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244708";"B";"Binding affinity to ABL1 Q252H mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00519";"Q252H"
"CHEMBL1244960";"B";"Binding affinity to RIPK4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219233";"B";"Millipore: Percentage of residual kinase activity of MAPK9 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219119";"B";"Millipore: Percentage of residual kinase activity of PRKD1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219409";"B";"Millipore: Percentage of residual kinase activity of PRKCE at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219394";"B";"Millipore: Percentage of residual kinase activity of AKT2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218947";"B";"Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219103";"B";"Millipore: Percentage of residual kinase activity of HIPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218993";"B";"Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219169";"B";"Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219277";"B";"Millipore: Percentage of residual kinase activity of CDC42BPB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219398";"B";"Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219210";"B";"Millipore: Percentage of residual kinase activity of IGF1R at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219343";"B";"Millipore: Percentage of residual kinase activity of EEF2K at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244565";"B";"Binding affinity to PIK3C2B";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244990";"B";"Binding affinity to STK36";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244738";"B";"Binding affinity to BMX";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244823";"B";"Binding affinity to EPHB4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244862";"B";"Binding affinity to HIPK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244569";"B";"Binding affinity to PIK3CA E542K mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P42336";"E542K"
"CHEMBL1244851";"B";"Binding affinity to FLT4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219254";"B";"Millipore: Percentage of residual kinase activity of MAPK1 at 10uM relative to control. Control inhibitor: ERK Inhibitor II at 30.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219278";"B";"Millipore: Percentage of residual kinase activity of CDC42BPB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219303";"B";"Millipore: Percentage of residual kinase activity of NEK3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219329";"B";"Millipore: Percentage of residual kinase activity of WNK3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219147";"B";"Millipore: Percentage of residual kinase activity of PTK2B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219171";"B";"Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219356";"B";"Millipore: Percentage of residual kinase activity of NLK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219154";"B";"Millipore: Percentage of residual kinase activity of ROCK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218970";"B";"Millipore: Percentage of residual kinase activity of CDK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219076";"B";"Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219358";"B";"Millipore: Percentage of residual kinase activity of PAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219217";"B";"Millipore: Percentage of residual kinase activity of INSR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218949";"B";"Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218973";"B";"Millipore: Percentage of residual kinase activity of CDK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218987";"B";"Millipore: Percentage of residual kinase activity of CHEK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219285";"B";"Millipore: Percentage of residual kinase activity of STK4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219372";"B";"Millipore: Percentage of residual kinase activity of TNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219008";"B";"Millipore: Percentage of residual kinase activity of CAMK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219052";"B";"Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219010";"B";"Millipore: Percentage of residual kinase activity of CAMK2B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219211";"B";"Millipore: Percentage of residual kinase activity of CHUK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219212";"B";"Millipore: Percentage of residual kinase activity of CHUK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219236";"B";"Millipore: Percentage of residual kinase activity of MAPK10 at 10uM relative to control. Control inhibitor: JAK Inhibitor I at 30.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244707";"B";"Binding affinity to ABL1 M351T mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00519";"M351T"
"CHEMBL1244729";"B";"Binding affinity to AURKA";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244783";"B";"Binding affinity to CSNK2A2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244482";"B";"Binding affinity to LIMK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244929";"B";"Binding affinity to PKMYT1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244974";"B";"Binding affinity to RPS6KA6(Kin.Dom.2-C-terminal)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244727";"B";"Binding affinity to ASK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL3991717";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991771";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"238";"238";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991653";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991678";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"198";"198";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2219235";"B";"Millipore: Percentage of residual kinase activity of MAPK10 at 1uM relative to control. Control inhibitor: JAK Inhibitor I at 30.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219246";"B";"Millipore: Percentage of residual kinase activity of LCK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219300";"B";"Millipore: Percentage of residual kinase activity of NEK11 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219291";"B";"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219209";"B";"Millipore: Percentage of residual kinase activity of IGF1R at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218981";"B";"Millipore: Percentage of residual kinase activity of CDK6 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219214";"B";"Millipore: Percentage of residual kinase activity of IKBKB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3991811";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991661";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"240";"240";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991891";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"234";"234";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991644";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991687";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"233";"233";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991622";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"240";"240";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991659";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"241";"241";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991878";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991901";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991663";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991621";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991702";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991680";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991703";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"241";"241";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991704";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"203";"203";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991705";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991603";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991924";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"239";"239";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991657";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991868";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL4672389";"B";"Inhibition of N-His6-tagged human AspH (315-755) expressed in Escherichia coli BL21 (DE3) using 1 uM hFX-CP as substrate mixture with high 200 uM 2OG, 100 uM L-ascorbic acid and 2 uM FAS incubated for 35 mins by MS analysis";"Homo sapiens";"12";"12";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4665871";"33069066";"10.1016/j.bmc.2020.115675";"2020";"Bioorg Med Chem";"28";"115675";"115675";"";"";"";"";"";""
"CHEMBL4672391";"B";"Inhibition of N-His6-tagged human AspH (315-755) expressed in Escherichia coli BL21 (DE3) using high 10 uM hFX-CP as substrate mixture with 10 uM 2OG, 100 uM L-ascorbic acid and 2 uM FAS incubated for 35 mins by MS analysis";"Homo sapiens";"12";"12";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4665871";"33069066";"10.1016/j.bmc.2020.115675";"2020";"Bioorg Med Chem";"28";"115675";"115675";"";"";"";"";"";""
"CHEMBL3991799";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1060194";"B";"Binding constant for FLT3(D835H) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P36888";"D835H"
"CHEMBL1060342";"B";"Binding constant for RPS6KA2(Kin.Dom.1 - N-terminal) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1037545";"B";"Binding constant for RPS6KA5(Kin.Dom.1 - C-terminal) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051287";"B";"Binding constant for EPHA2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1245022";"B";"Binding affinity to VEGFR2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244512";"B";"Binding affinity to MET";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244928";"B";"Binding affinity to PKAC-beta";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244947";"B";"Binding affinity to PRP4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245015";"B";"Binding affinity to TXK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245021";"B";"Binding affinity to ULK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244830";"B";"Binding affinity to ERK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244986";"B";"Binding affinity to SRPK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245010";"B";"Binding affinity to TRKA";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244824";"B";"Binding affinity to EPHB6";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244767";"B";"Binding affinity to CHEK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244794";"B";"Binding affinity to DMPK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244838";"B";"Binding affinity to FGFR1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244857";"B";"Binding affinity to GRK4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244461";"B";"Binding affinity to INSRR";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244526";"B";"Binding affinity to MST2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244551";"B";"Binding affinity to PAK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244789";"B";"Binding affinity to DCAMKL2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244863";"B";"Binding affinity to HIPK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244867";"B";"Binding affinity to HUNK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244490";"B";"Binding affinity to MAP3K15";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244827";"B";"Binding affinity to ERBB4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1060246";"B";"Binding constant for FLT4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908492";"B";"Binding constant for MET(M1250T) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P08581";"M1250T"
"CHEMBL1908568";"B";"Binding constant for PAK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908529";"B";"Binding constant for IKK-alpha kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908433";"B";"Binding constant for RPS6KA5(Kin.Dom.1-N-terminal) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908561";"B";"Binding constant for CTK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908662";"B";"Binding constant for LZK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908771";"B";"Binding constant for IKK-epsilon kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908410";"B";"Binding constant for ERK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908503";"B";"Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908565";"B";"Binding constant for MST1R kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908605";"B";"Binding constant for TEC kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908686";"B";"Binding constant for ABL1(T315I)-phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"T315I"
"CHEMBL1908822";"B";"Binding constant for CLK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908553";"B";"Binding constant for GSK3B kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908694";"B";"Binding constant for EGFR(E746-A750del) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908430";"B";"Binding constant for SIK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908573";"B";"Binding constant for PDPK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1060243";"B";"Binding constant for full-length DYRK1B";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051338";"B";"Binding constant for LOK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051310";"B";"Binding constant for PKN2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061070";"B";"Binding constant for EPHB3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061081";"B";"Binding constant for NEK9 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051279";"B";"Binding constant for AKT1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060249";"B";"Binding constant for LATS2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051253";"B";"Binding constant for PKN1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051311";"B";"Binding constant for PLK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061092";"B";"Binding constant for PLK3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063794";"B";"Binding constant for CDC2L2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1037548";"B";"Binding constant for MAP4K4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1052133";"B";"Binding constant for CAMK1D kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061905";"B";"Binding constant for MARK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061142";"B";"Binding constant for DRAK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061144";"B";"Binding constant for EPHA1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061178";"B";"Binding constant for full-length MST1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244492";"B";"Binding affinity to MAP3K3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1061131";"B";"Binding constant for ABL2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063697";"B";"Binding constant for ACVR1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060198";"B";"Binding constant for KIT(D816V) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P10721";"D816V"
"CHEMBL1063809";"B";"Binding constant for full-length NLK";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060174";"B";"Binding constant for ABL1(H396P) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P00519";"H396P"
"CHEMBL1244773";"B";"Binding affinity to CLK4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244484";"B";"Binding affinity to LOK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244995";"B";"Binding affinity to TAOK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244782";"B";"Binding affinity to CSNK2A1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908628";"B";"Binding constant for CLK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908740";"B";"Binding constant for PIK3CA(I800L) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P42336";"I800L"
"CHEMBL1244829";"B";"Binding affinity to ERK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244843";"B";"Binding affinity to FGR";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2363419";"F";"SANGER: Inhibition of human MFE-296 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MFE-296";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363789";"F";"SANGER: Inhibition of human TE-11 cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363663";"F";"SANGER: Inhibition of human SN12C cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SN12C";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363704";"F";"SANGER: Inhibition of human TALL-1 cell growth in a cell viability assay.";"Homo sapiens";"76";"77";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TALL-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1244779";"B";"Binding affinity to CSNK1G1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244959";"B";"Binding affinity to RIPK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244766";"B";"Binding affinity to CDKL5";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244861";"B";"Binding affinity to HCK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244924";"B";"Binding affinity to PIM3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL3562018";"F";"PubChem BioAssay. Immunotoxin (SS1P) sensitization/mitigation study - treatment arm.   (Class of assay: confirmatory) ";"";"401";"403";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4379572";"B";"Inhibition of wild type recombinant GST-tagged FLT3 (Y567 to S993 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells using Her2 peptide as substrate measured after 4 hrs in presence of ATP by Kinase-Glo Plus reagent-based luminescence assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"Sf9";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL4379634";"F";"Antiproliferative activity against human Kasumi-1 harboring c-kit N822K mutant assessed as cell growth inhibition after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Kasumi 1";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL1063711";"B";"Binding constant for FGFR3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062841";"B";"Binding constant for FGFR3(G697C) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P22607";"G697C"
"CHEMBL1051309";"B";"Binding constant for PKAC-alpha kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060260";"B";"Binding constant for PIK3CA kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062870";"B";"Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061185";"B";"Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2363648";"F";"SANGER: Inhibition of human SK-MEL-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MEL-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363750";"F";"SANGER: Inhibition of human BC-1 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BC1 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363157";"F";"SANGER: Inhibition of human CaR-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CaR-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363159";"F";"SANGER: Inhibition of human Calu-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Calu-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363716";"F";"SANGER: Inhibition of human 8-MG-BA cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"8-MG-BA";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363150";"F";"SANGER: Inhibition of human CPC-N cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CPC-N";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363711";"F";"SANGER: Inhibition of human 639-V cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"639-V";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363654";"F";"SANGER: Inhibition of human SK-N-AS cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-N-AS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363692";"F";"SANGER: Inhibition of human SW872 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW872";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363808";"F";"SANGER: Inhibition of human U-2-OS cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"U-2-OS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363694";"F";"SANGER: Inhibition of human SW948 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW948";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363810";"F";"SANGER: Inhibition of human U-698-M cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"U-698-M";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363361";"F";"SANGER: Inhibition of human KYSE-520 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-520 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363215";"F";"SANGER: Inhibition of human ES7 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES7";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363737";"F";"SANGER: Inhibition of human ACN cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ACN";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363743";"F";"SANGER: Inhibition of human ATN-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ATN-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363187";"F";"SANGER: Inhibition of human DSH1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DSH1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363769";"F";"SANGER: Inhibition of human C-33-A cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"C-33-A";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363162";"F";"SANGER: Inhibition of human Caov-4 cell growth in a cell viability assay.";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Caov-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363260";"F";"SANGER: Inhibition of human HCC1806 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1806";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363748";"F";"SANGER: Inhibition of human BB49-HNC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BB49-HNC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363541";"F";"SANGER: Inhibition of human NCI-H69 cell growth in a cell viability assay.";"Homo sapiens";"121";"122";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H69";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363349";"F";"SANGER: Inhibition of human KS-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363383";"F";"SANGER: Inhibition of human LNCaP-Clone-FGC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LNCaP-Clone-FGC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219122";"B";"Millipore: Percentage of residual kinase activity of PRKD2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1063802";"B";"Binding constant for full-length MARK3";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063806";"B";"Binding constant for full-length MST4";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2363783";"F";"SANGER: Inhibition of human CAL-51 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-51";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363153";"F";"SANGER: Inhibition of human CTV-1 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CTV-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363140";"F";"SANGER: Inhibition of human COLO-800 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-800";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363142";"F";"SANGER: Inhibition of human COLO-829 cell growth in a cell viability assay.";"Homo sapiens";"134";"136";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-829";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363333";"F";"SANGER: Inhibition of human KG-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KG-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363528";"F";"SANGER: Inhibition of human NCI-H441 cell growth in a cell viability assay.";"Homo sapiens";"98";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H441";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363638";"F";"SANGER: Inhibition of human SJRH30 cell growth in a cell viability assay.";"Homo sapiens";"89";"89";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SJRH30";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363639";"F";"SANGER: Inhibition of human SJSA-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SJSA-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363806";"F";"SANGER: Inhibition of human TYK-nu cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TYK-nu";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363220";"F";"SANGER: Inhibition of human EW-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363364";"F";"SANGER: Inhibition of human L-428 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"L-428";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363183";"F";"SANGER: Inhibition of human DMS-53 cell growth in a cell viability assay.";"Homo sapiens";"46";"47";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DMS-53";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363779";"F";"SANGER: Inhibition of human CAL-148 cell growth in a cell viability assay.";"Homo sapiens";"76";"77";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-148";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363365";"F";"SANGER: Inhibition of human L-540 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"L-540";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363768";"F";"SANGER: Inhibition of human BxPC-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BXPC-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363319";"F";"SANGER: Inhibition of human JAR cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"JAR";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363163";"F";"SANGER: Inhibition of human Capan-2 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Capan-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363819";"F";"SANGER: Inhibition of human UMC-11 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UMC-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363257";"F";"SANGER: Inhibition of human HCC1419 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1419";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363391";"F";"SANGER: Inhibition of human LU-134-A cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LU-134-A";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363294";"F";"SANGER: Inhibition of human HT-144 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT-144";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363362";"F";"SANGER: Inhibition of human KYSE-70 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-70 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363756";"F";"SANGER: Inhibition of human BFTC-909 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BFTC-909";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363535";"F";"SANGER: Inhibition of human NCI-H526 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H526";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363422";"F";"SANGER: Inhibition of human MG-63 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MG-63";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363281";"F";"SANGER: Inhibition of human HN cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HN";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363375";"F";"SANGER: Inhibition of human LB996-RCC cell growth in a cell viability assay.";"Homo sapiens";"110";"112";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB996-RCC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363156";"F";"SANGER: Inhibition of human Ca9-22 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Ca9-22";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363649";"F";"SANGER: Inhibition of human SK-MEL-30 cell growth in a cell viability assay.";"Homo sapiens";"98";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MEL-30";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363651";"F";"SANGER: Inhibition of human SK-MES-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MES-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363653";"F";"SANGER: Inhibition of human SK-MM-2 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MM-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363809";"F";"SANGER: Inhibition of human U-266 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"U-266";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363199";"F";"SANGER: Inhibition of human ECC12 cell growth in a cell viability assay.";"Homo sapiens";"29";"29";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ECC12";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363520";"F";"SANGER: Inhibition of human NCI-H2452 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2452";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363573";"F";"SANGER: Inhibition of human ONS-76 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ONS-76";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363684";"F";"SANGER: Inhibition of human SW1990 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1990";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363503";"F";"SANGER: Inhibition of human NCI-H2087 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2087";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363386";"F";"SANGER: Inhibition of human LP-1 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LP-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363424";"F";"SANGER: Inhibition of human MHH-ES-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MHH-ES-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363457";"F";"SANGER: Inhibition of human NB5 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363243";"F";"SANGER: Inhibition of human GI-ME-N cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GI-ME-N";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363317";"F";"SANGER: Inhibition of human J-RT3-T3-5 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"J-RT3-T3-5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363762";"F";"SANGER: Inhibition of human BPH-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BPH-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363314";"F";"SANGER: Inhibition of human IST-MES1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IST-MES1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363348";"F";"SANGER: Inhibition of human KP-N-YS cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KP-N-YS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363712";"F";"SANGER: Inhibition of human 647-V cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"647-V";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363252";"F";"SANGER: Inhibition of human HAL-01 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HAL-01";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363661";"F";"SANGER: Inhibition of human SKG-IIIa cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SKG-IIIa";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363468";"F";"SANGER: Inhibition of human NCI-H1304 cell growth in a cell viability assay.";"Homo sapiens";"128";"129";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1304";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363469";"F";"SANGER: Inhibition of human NCI-H1355 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1355";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363289";"F";"SANGER: Inhibition of human HSC-4 cell growth in a cell viability assay.";"Homo sapiens";"73";"74";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HSC-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363188";"F";"SANGER: Inhibition of human DU-145 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DU-145";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363506";"F";"SANGER: Inhibition of human NCI-H2122 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2122";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363374";"F";"SANGER: Inhibition of human LB831-BLC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB831-BLC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2218983";"B";"Millipore: Percentage of residual kinase activity of CDK7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219276";"B";"Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218996";"B";"Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219020";"B";"Millipore: Percentage of residual kinase activity of DAPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218955";"B";"Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218978";"B";"Millipore: Percentage of residual kinase activity of CDK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219238";"B";"Millipore: Percentage of residual kinase activity of KDR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219004";"B";"Millipore: Percentage of residual kinase activity of CLK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219028";"B";"Millipore: Percentage of residual kinase activity of DMPK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219029";"B";"Millipore: Percentage of residual kinase activity of DMPK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219226";"B";"Millipore: Percentage of residual kinase activity of ITK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219265";"B";"Millipore: Percentage of residual kinase activity of MINK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219377";"B";"Millipore: Percentage of residual kinase activity of PRKAA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 200 uM AMP";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219032";"B";"Millipore: Percentage of residual kinase activity of DYRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219158";"B";"Millipore: Percentage of residual kinase activity of MST1R at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219079";"B";"Millipore: Percentage of residual kinase activity of FLT3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219340";"B";"Millipore: Percentage of residual kinase activity of KIT at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219090";"B";"Millipore: Percentage of residual kinase activity of GRK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219091";"B";"Millipore: Percentage of residual kinase activity of GRK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219096";"B";"Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219219";"B";"Millipore: Percentage of residual kinase activity of IRAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219247";"B";"Millipore: Percentage of residual kinase activity of LCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219269";"B";"Millipore: Percentage of residual kinase activity of MAP2K7 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219070";"B";"Millipore: Percentage of residual kinase activity of FER at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219111";"B";"Millipore: Percentage of residual kinase activity of IGF1R at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219215";"B";"Millipore: Percentage of residual kinase activity of INSR at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219003";"B";"Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219097";"B";"Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219274";"B";"Millipore: Percentage of residual kinase activity of MAP3K9 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1908483";"B";"Binding constant for KIT kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL2363298";"F";"SANGER: Inhibition of human HTC-C3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HTC-C3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363669";"F";"SANGER: Inhibition of human SNU-475 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-475";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2218961";"B";"Millipore: Percentage of residual kinase activity of BLK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363625";"F";"SANGER: Inhibition of human SCC-3 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SCC-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363212";"F";"SANGER: Inhibition of human ES4 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363206";"F";"SANGER: Inhibition of human EHEB cell growth in a cell viability assay.";"Homo sapiens";"69";"69";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EHEB";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1244834";"B";"Binding affinity to ERN1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244471";"B";"Binding affinity to JNK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244963";"B";"Binding affinity to ROS1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245011";"B";"Binding affinity to TRKB";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244724";"B";"Binding affinity to AMPK-alpha2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244864";"B";"Binding affinity to HIPK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244467";"B";"Binding affinity to JH1 catalytic domain JAK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244952";"B";"Binding affinity to RET M918T mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P07949";"M918T"
"CHEMBL1244997";"B";"Binding affinity to TBK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244798";"B";"Binding affinity to DYRK1A";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244951";"B";"Binding affinity to RET";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244699";"F";"Cytotoxicity against human MV4-11 cells after 72 hrs by cell titer-blue assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244709";"B";"Binding affinity to ABL1 T315I mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00519";"T315I"
"CHEMBL1245012";"B";"Binding affinity to TRKC";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244734";"B";"Binding affinity to BLK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244744";"B";"Binding affinity to BTK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244787";"B";"Binding affinity to DAPK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244463";"B";"Binding affinity to IRAK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244473";"B";"Binding affinity to KIT D816V mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P10721";"D816V"
"CHEMBL1244485";"B";"Binding affinity to LTK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244524";"B";"Binding affinity to MST1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244543";"B";"Binding affinity to NLK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244483";"B";"Binding affinity to LKB1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244507";"B";"Binding affinity to MEK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244544";"B";"Binding affinity to OSR1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244935";"B";"Binding affinity to PLK4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245000";"B";"Binding affinity to TGFBR1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245016";"B";"Binding affinity to TYK2(JH1domain-catalytic)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244772";"B";"Binding affinity to CLK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244469";"B";"Binding affinity to JNK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244922";"B";"Binding affinity to PIM1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244936";"B";"Binding affinity to PRKCD";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244941";"B";"Binding affinity to PRKD2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244712";"B";"Binding affinity to ACVR1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244550";"B";"Binding affinity to PAK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245003";"B";"Binding affinity to TIE2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245024";"B";"Binding affinity to WEE2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2218943";"B";"Millipore: Percentage of residual kinase activity of MAP3K5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1908658";"B";"Binding constant for TGFBR1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908673";"B";"Binding constant for PRKX kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL2219260";"B";"Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219039";"B";"Millipore: Percentage of residual kinase activity of EPHA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219396";"B";"Millipore: Percentage of residual kinase activity of AKT3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3991623";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991666";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991922";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991877";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"225";"225";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991853";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"235";"235";"BAO_0000220";"subcellular format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991854";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991807";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"215";"215";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991635";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"240";"240";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1244755";"B";"Binding affinity to CDC2L1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2363450";"F";"SANGER: Inhibition of human NALM-6 cell growth in a cell viability assay.";"Homo sapiens";"76";"77";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NALM-6";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1051336";"B";"Binding constant for KIT(V559D,T670I) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P10721";"V559D,T670I"
"CHEMBL1061139";"B";"Binding constant for CLK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061896";"B";"Binding constant for ERBB2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063799";"B";"Binding constant for ERK5 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060193";"B";"Binding constant for ERK8 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061156";"B";"Binding constant for PRKD2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL4379640";"B";"Inhibition of FLT3 ITD/F691L double mutant in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"BaF3";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL1908552";"B";"Binding constant for FRK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908555";"B";"Binding constant for JAK1(JH2domain-pseudokinase) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908638";"B";"Binding constant for CDKL1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908754";"B";"Binding constant for TYRO3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908448";"B";"Binding constant for PIP5K1C kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908781";"B";"Binding constant for HUNK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908791";"B";"Binding constant for CDK11 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908437";"B";"Binding constant for LRRK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL2219218";"B";"Millipore: Percentage of residual kinase activity of INSR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219095";"B";"Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219222";"B";"Millipore: Percentage of residual kinase activity of IRAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219245";"B";"Millipore: Percentage of residual kinase activity of LCK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218963";"B";"Millipore: Percentage of residual kinase activity of BMX at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219266";"B";"Millipore: Percentage of residual kinase activity of MINK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219267";"B";"Millipore: Percentage of residual kinase activity of MAP2K6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4, 1 mg/mL BSA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219371";"B";"Millipore: Percentage of residual kinase activity of TNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218954";"B";"Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219272";"B";"Millipore: Percentage of residual kinase activity of MYLK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219071";"B";"Millipore: Percentage of residual kinase activity of FER at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218956";"B";"Millipore: Percentage of residual kinase activity of PTK6 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218974";"B";"Millipore: Percentage of residual kinase activity of CDK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1061932";"B";"Binding constant for full-length TNNI3K";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061901";"B";"Binding constant for KIT(V559D,V654A) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P10721";"V559D,V654A"
"CHEMBL1050830";"B";"Binding constant for MKNK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1050827";"B";"Binding constant for MLK3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062845";"B";"Binding constant for MST3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1050836";"B";"Binding constant for MYLK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063709";"B";"Binding constant for EPHB2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1049903";"B";"Binding constant for MARK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062866";"B";"Binding constant for PRKD3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061982";"B";"Binding constant for full-length SNF1LK2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051313";"B";"Binding constant for full-length SRPK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062858";"B";"Binding constant for NEK6 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1050828";"B";"Binding constant for PAK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908626";"B";"Binding constant for BRSK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1060196";"B";"Binding constant for full-length JNK2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908753";"B";"Binding constant for TESK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908489";"B";"Binding constant for KIT(V559D,T670I) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P10721";"V559D,T670I"
"CHEMBL1908585";"B";"Binding constant for ERK5 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908592";"B";"Binding constant for MEK6 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908603";"B";"Binding constant for S6K1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908425";"B";"Binding constant for NIM1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908461";"B";"Binding constant for CLK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1050839";"B";"Binding constant for EGFR(S752-I759del) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908426";"B";"Binding constant for FAK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908587";"B";"Binding constant for p38-beta kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1837493";"F";"Antiproliferative activity against mouse BAF3 cells transformed with ZNF198-FGFR1 construct";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"BaF3";"";"CHEMBL1833940";"21936542";"10.1021/jm2006222";"2011";"J Med Chem";"54";"7066";"7083";"";"";"";"";"";""
"CHEMBL1050835";"B";"Binding constant for full-length IKK-epsilon";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051288";"B";"Binding constant for full-length LKB1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063789";"B";"Binding constant for ABL1(E255K) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P00519";"E255K"
"CHEMBL1908478";"B";"Binding constant for CDK4-cyclinD3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908519";"B";"Binding constant for CDKL3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908807";"B";"Binding constant for TRPM6 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908635";"B";"Binding constant for FLT3(K663Q) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P36888";"K663Q"
"CHEMBL1908780";"B";"Binding constant for LATS2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1062782";"B";"Binding constant for full-length PCTK3";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061935";"B";"Binding constant for WEE1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908761";"B";"Binding constant for PIM2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908768";"B";"Binding constant for STK39 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908491";"B";"Binding constant for MET kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908497";"B";"Binding constant for IGF1R kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908530";"B";"Binding constant for CSNK1G2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908541";"B";"Binding constant for CDK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908598";"B";"Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908649";"B";"Binding constant for EPHA4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908819";"B";"Binding constant for RET(M918T) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P07949";"M918T"
"CHEMBL1908420";"B";"Binding constant for CSNK1A1L kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908422";"B";"Binding constant for NEK11 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908692";"B";"Binding constant for CSF1R kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908750";"B";"Binding constant for PRKG2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1037547";"B";"Binding constant for full-length CSK";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2363792";"F";"SANGER: Inhibition of human TE-441-T cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-441-T";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363793";"F";"SANGER: Inhibition of human TE-5 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363204";"F";"SANGER: Inhibition of human EFO-27 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EFO-27";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363782";"F";"SANGER: Inhibition of human CAL-39 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-39";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363719";"F";"SANGER: Inhibition of human A101D cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A101D";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363754";"F";"SANGER: Inhibition of human BEN cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BEN";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363421";"F";"SANGER: Inhibition of human MFM-223 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MFM-223";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363545";"F";"SANGER: Inhibition of human NCI-H727 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H727";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363273";"F";"SANGER: Inhibition of human HDLM-2 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HDLM-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363480";"F";"SANGER: Inhibition of human NCI-H1648 cell growth in a cell viability assay.";"Homo sapiens";"133";"135";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1648";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363562";"F";"SANGER: Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NTERA-2-cl-D1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363631";"F";"SANGER: Inhibition of human SF268 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SF-268";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363224";"F";"SANGER: Inhibition of human EW-16 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-16";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363553";"F";"SANGER: Inhibition of human NCI-SNU-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1061141";"B";"Binding constant for full-length CSNK2A2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060189";"B";"Binding constant for full-length DRAK2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1037552";"B";"Binding constant for full-length ERK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063712";"B";"Binding constant for ITK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063801";"B";"Binding constant for JAK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060197";"B";"Binding constant for KIT kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063730";"B";"Binding constant for HCK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061075";"B";"Binding constant for IGF1R kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060179";"B";"Binding constant for CAMK4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063793";"B";"Binding constant for CAMKK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061133";"B";"Binding constant for BMPR2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051281";"B";"Binding constant for BRAF kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061904";"B";"Binding constant for MAPKAPK5 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2218995";"B";"Millipore: Percentage of residual kinase activity of CSNK1G3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219019";"B";"Millipore: Percentage of residual kinase activity of CAMK1D at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219043";"B";"Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219013";"B";"Millipore: Percentage of residual kinase activity of CAMK2G at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1908794";"B";"Binding constant for TNNI3K kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908466";"B";"Binding constant for AURKC kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL2219094";"B";"Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219055";"B";"Millipore: Percentage of residual kinase activity of EPHB3 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1060191";"B";"Binding constant for EPHB1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908656";"B";"Binding constant for MAP4K2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908840";"B";"Binding constant for CAMKK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908697";"B";"Binding constant for EGFR(L747-E749del, A750P) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908494";"B";"Binding constant for PHKG2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908569";"B";"Binding constant for PAK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908597";"B";"Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908683";"B";"Binding constant for ABL1(Q252H)-non phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"Q252H"
"CHEMBL1908404";"B";"Binding constant for DCAMKL3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908517";"B";"Binding constant for ACVR2B kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908520";"B";"Binding constant for MKNK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908581";"B";"Binding constant for PRKD1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908643";"B";"Binding constant for BRAF kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908707";"B";"Binding constant for FER kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908709";"B";"Binding constant for GAK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908785";"B";"Binding constant for ARK5 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908685";"B";"Binding constant for ABL1(T315I)-non phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"T315I"
"CHEMBL2219112";"B";"Millipore: Percentage of residual kinase activity of PRKCZ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219369";"B";"Millipore: Percentage of residual kinase activity of PASK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1063705";"B";"Binding constant for DCAMKL1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063795";"B";"Binding constant for DCAMKL2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061080";"B";"Binding constant for MYO3A kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061897";"B";"Binding constant for ERBB4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244856";"B";"Binding affinity to GRK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1061145";"B";"Binding constant for EPHA3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060244";"B";"Binding constant for EPHA6 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063715";"B";"Binding constant for MAP4K3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061072";"B";"Binding constant for FES kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2114803";"F";"PubChem BioAssay. Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 8 hrs). (Class of assay: confirmatory) ";"";"226";"228";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991913";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL4672388";"B";"Inhibition of N-His6-tagged human AspH (315-755) expressed in Escherichia coli BL21 (DE3) using 1 uM hFX-CP as substrate mixture with 3 uM 2OG, 100 uM L-ascorbic acid and 2 uM FAS incubated for 35 mins by MS analysis";"Homo sapiens";"12";"12";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4665871";"33069066";"10.1016/j.bmc.2020.115675";"2020";"Bioorg Med Chem";"28";"115675";"115675";"";"";"";"";"";""
"CHEMBL3991824";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991798";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1244816";"B";"Binding affinity to EPHA5";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244819";"B";"Binding affinity to EPHA8";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244821";"B";"Binding affinity to EPHB2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244855";"B";"Binding affinity to GCN2 Kin.Dom.2, S808G mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"Q9P2K8";"S808G"
"CHEMBL1244460";"B";"Binding affinity to INSR";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244478";"B";"Binding affinity to LATS1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244513";"B";"Binding affinity to MET M1250T mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P08581";"M1250T"
"CHEMBL1244531";"B";"Binding affinity to MYLK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244549";"B";"Binding affinity to PAK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245019";"B";"Binding affinity to ULK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244728";"B";"Binding affinity to ASK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1068699";"B";"Inhibition of CSF1-stimulated human FMS autophosphorylation expressed in growth factor dependent mouse FDC-P1 cells assessed as phosphorylated receptor level at 5 nM relative to control by Western blot";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"FDC-P1";"";"CHEMBL1157596";"20156689";"10.1016/j.bmc.2010.01.056";"2010";"Bioorg Med Chem";"18";"1789";"1797";"";"";"";"";"";""
"CHEMBL3991710";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991625";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"236";"236";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991919";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991732";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"233";"233";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991904";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1244989";"B";"Binding affinity to STK35";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1062839";"B";"Binding constant for EGFR(L858R) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P00533";"L858R"
"CHEMBL1244530";"B";"Binding affinity to MYLK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245001";"B";"Binding affinity to TGFBR2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244534";"B";"Binding affinity to NDR1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244946";"B";"Binding affinity to PRKX";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1063731";"B";"Binding constant for MET kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244726";"B";"Binding affinity to ARK5";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244917";"B";"Binding affinity to PIK3CA Q546K mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P42336";"Q546K"
"CHEMBL2219089";"B";"Millipore: Percentage of residual kinase activity of GRK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218991";"B";"Millipore: Percentage of residual kinase activity of CSNK1G1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219311";"B";"Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218976";"B";"Millipore: Percentage of residual kinase activity of CDK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1068698";"B";"Inhibition of CSF1-stimulated human FMS autophosphorylation expressed in growth factor dependent mouse FDC-P1 cells assessed as phosphorylated receptor level at 50 nM relative to control by Western blot";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"FDC-P1";"";"CHEMBL1157596";"20156689";"10.1016/j.bmc.2010.01.056";"2010";"Bioorg Med Chem";"18";"1789";"1797";"";"";"";"";"";""
"CHEMBL1244730";"B";"Binding affinity to AURKB";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244487";"B";"Binding affinity to LZK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244778";"B";"Binding affinity to CSNK1E";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219240";"B";"Millipore: Percentage of residual kinase activity of LIMK1 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218977";"B";"Millipore: Percentage of residual kinase activity of CDK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244697";"B";"Inhibition of FLT3 ITD mutant autophosphorylation in human RS4-11 cells after 2 hrs by electrochemiluminescence assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"RS4-11";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244462";"B";"Binding affinity to IRAK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244477";"B";"Binding affinity to KIT V559D,V654A mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P10721";"V559D,V654A"
"CHEMBL1244533";"B";"Binding affinity to MYO3B";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244522";"B";"Binding affinity to MRCKA";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219315";"B";"Millipore: Percentage of residual kinase activity of NTRK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219167";"B";"Millipore: Percentage of residual kinase activity of RPS6KA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244570";"B";"Binding affinity to PIK3CA E545A mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P42336";"E545A"
"CHEMBL1908571";"B";"Binding constant for PCTK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1244762";"B";"Binding affinity to CDK8";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244763";"B";"Binding affinity to CDK9";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244470";"B";"Binding affinity to JNK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244505";"B";"Binding affinity to MEK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244536";"B";"Binding affinity to NEK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244817";"B";"Binding affinity to EPHA6";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219225";"B";"Millipore: Percentage of residual kinase activity of ITK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219221";"B";"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219357";"B";"Millipore: Percentage of residual kinase activity of PAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219376";"B";"Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244940";"B";"Binding affinity to PRKD1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219223";"B";"Millipore: Percentage of residual kinase activity of INSRR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244742";"B";"Binding affinity to BRSK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244832";"B";"Binding affinity to ERK5";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2218972";"B";"Millipore: Percentage of residual kinase activity of CDK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219299";"B";"Millipore: Percentage of residual kinase activity of NEK11 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219380";"B";"Millipore: Percentage of residual kinase activity of PRKAA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 200 uM AMP";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219381";"B";"Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219243";"B";"Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219293";"B";"Millipore: Percentage of residual kinase activity of MET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219087";"B";"Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219088";"B";"Millipore: Percentage of residual kinase activity of GRK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244835";"B";"Binding affinity to FAK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244839";"B";"Binding affinity to FGFR2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219216";"B";"Millipore: Percentage of residual kinase activity of INSR at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244769";"B";"Binding affinity to CIT";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908672";"B";"Binding constant for PLK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908679";"B";"Binding constant for ABL1(F317L)-phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"F317L"
"CHEMBL1062837";"B";"Binding constant for CDK11 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060200";"B";"Binding constant for MLCK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063805";"B";"Binding constant for MST2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061155";"B";"Binding constant for PRKD1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL3991774";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991715";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991772";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1060176";"B";"Binding constant for AMPK-alpha2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060180";"B";"Binding constant for DDR2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060341";"B";"Binding constant for PLK4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061926";"B";"Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062787";"B";"Binding constant for SLK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051261";"B";"Binding constant for VEGFR2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908505";"B";"Binding constant for TRKA kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL3991713";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1061132";"B";"Binding constant for full-length ADCK4";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063800";"B";"Binding constant for FGFR4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL3991719";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1908786";"B";"Binding constant for AAK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908644";"B";"Binding constant for BRAF(V600E) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P15056";"V600E"
"CHEMBL1908612";"B";"Binding constant for PIP5K2B kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908629";"B";"Binding constant for CLK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908500";"B";"Binding constant for CHEK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908586";"B";"Binding constant for JNK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908634";"B";"Binding constant for FLT3(ITD) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL3991755";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991675";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991650";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1908642";"B";"Binding constant for BMPR1A kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908417";"B";"Binding constant for HIPK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908648";"B";"Binding constant for EPHA2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908719";"B";"Binding constant for MUSK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908479";"B";"Binding constant for FGFR3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908574";"B";"Binding constant for PIK3C2B kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL3991739";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1061130";"B";"Binding constant for ABL1(Y253F) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P00519";"Y253F"
"CHEMBL1051335";"B";"Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL3991899";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"237";"237";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991856";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991813";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991815";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"166";"166";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1062789";"B";"Binding constant for YANK3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908606";"B";"Binding constant for TGFBR2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL3991694";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1908745";"B";"Binding constant for PRKCD kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL3991709";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991921";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"235";"235";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991894";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"239";"239";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991662";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991618";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1908796";"B";"Binding constant for TAOK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908429";"B";"Binding constant for PYK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908724";"B";"Binding constant for MAP3K4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908727";"B";"Binding constant for LOK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908741";"B";"Binding constant for PIK3CA(M1043I) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P42336";"M1043I"
"CHEMBL1908773";"B";"Binding constant for PLK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908833";"B";"Binding constant for YSK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908792";"B";"Binding constant for SIK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL3991633";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991861";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"236";"236";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991791";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1061985";"B";"Binding constant for full-length YANK2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL3991910";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"229";"229";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991888";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991726";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363191";"F";"SANGER: Inhibition of human Daoy cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Daoy";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363207";"F";"SANGER: Inhibition of human EKVX cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EKVX ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991866";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363339";"F";"SANGER: Inhibition of human KMOE-2 cell growth in a cell viability assay.";"Homo sapiens";"104";"105";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KMOE-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1050837";"B";"Binding constant for ALK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2363445";"F";"SANGER: Inhibition of human MZ1-PC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MZ1-PC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363561";"F";"SANGER: Inhibition of human NOS-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NOS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363597";"F";"SANGER: Inhibition of human REH cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"REH";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1062832";"B";"Binding constant for AKT2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2363265";"F";"SANGER: Inhibition of human HCC2998 cell growth in a cell viability assay.";"Homo sapiens";"113";"114";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC 2998";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991903";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991839";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991757";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363409";"F";"SANGER: Inhibition of human MDA-MB-361 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-361";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991859";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3215154";"F";"PubChem BioAssay. Cell Proliferation Assay Versus the ED40515 IL2 Independent  ATL cell lines.   (Class of assay: confirmatory) ";"";"198";"198";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1060241";"B";"Binding constant for full-length CSNK2A1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL3991800";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363396";"F";"SANGER: Inhibition of human LU-99A cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LU-99A";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363254";"F";"SANGER: Inhibition of human HCC1143 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1143";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363325";"F";"SANGER: Inhibition of human K052 cell growth in a cell viability assay.";"Homo sapiens";"71";"72";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"K052";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1061074";"B";"Binding constant for full-length GSK3B";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2363635";"F";"SANGER: Inhibition of human SHP-77 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SHP-77";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363334";"F";"SANGER: Inhibition of human KGN cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KGN";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363446";"F";"SANGER: Inhibition of human MZ2-MEL cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MZ2-MEL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363540";"F";"SANGER: Inhibition of human NCI-H661 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H661";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363376";"F";"SANGER: Inhibition of human LC-1F cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LC-1F";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363377";"F";"SANGER: Inhibition of human LC-2-ad cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LC-2-ad";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363412";"F";"SANGER: Inhibition of human MDA-MB-468 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-468";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363414";"F";"SANGER: Inhibition of human MEG-01 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MEG-01";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363485";"F";"SANGER: Inhibition of human NCI-H1694 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1694";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363417";"F";"SANGER: Inhibition of human MES-SA cell growth in a cell viability assay.";"Homo sapiens";"46";"47";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MES-SA ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363235";"F";"SANGER: Inhibition of human G-402 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"G-402";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219153";"B";"Millipore: Percentage of residual kinase activity of ROCK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219130";"B";"Millipore: Percentage of residual kinase activity of PKN2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219327";"B";"Millipore: Percentage of residual kinase activity of WNK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219364";"B";"Millipore: Percentage of residual kinase activity of PAK7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1908749";"B";"Binding constant for PRKG1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908610";"B";"Binding constant for TYK2(JH2domain-pseudokinase) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908594";"B";"Binding constant for RAF1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908671";"B";"Binding constant for PIK3CD kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908401";"B";"Binding constant for NEK9 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908646";"B";"Binding constant for CSNK1G3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908619";"B";"Binding constant for CAMK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908442";"B";"Binding constant for PKN1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908655";"B";"Binding constant for PIK3C2G kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL2363258";"F";"SANGER: Inhibition of human HCC1569 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1569";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363551";"F";"SANGER: Inhibition of human NCI-H889 cell growth in a cell viability assay.";"Homo sapiens";"76";"77";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H889";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363264";"F";"SANGER: Inhibition of human HCC2218 cell growth in a cell viability assay.";"Homo sapiens";"121";"122";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC2218";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363788";"F";"SANGER: Inhibition of human TE-10 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363679";"F";"SANGER: Inhibition of human SW1417 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1417";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363301";"F";"SANGER: Inhibition of human HuCCT1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HuCCT1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363812";"F";"SANGER: Inhibition of human U031 cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UO-31";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363634";"F";"SANGER: Inhibition of human SH-4 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SH-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363278";"F";"SANGER: Inhibition of human HL-60 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HL-60";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363139";"F";"SANGER: Inhibition of human COLO-792 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-792";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363177";"F";"SANGER: Inhibition of human DG-75 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DG-75";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363734";"F";"SANGER: Inhibition of human A704 cell growth in a cell viability assay.";"Homo sapiens";"117";"118";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A704";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219227";"B";"Millipore: Percentage of residual kinase activity of JAK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363613";"F";"SANGER: Inhibition of human RT-112 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RT-112";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363833";"F";"SANGER: Inhibition of human CAPAN-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAPAN-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363805";"F";"SANGER: Inhibition of human TUR cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TUR";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363210";"F";"SANGER: Inhibition of human ES1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363211";"F";"SANGER: Inhibition of human ES3 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363167";"F";"SANGER: Inhibition of human D-283MED cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D283 Med";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363725";"F";"SANGER: Inhibition of human A3-KAW cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A3-KAW";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363542";"F";"SANGER: Inhibition of human NCI-H716 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H716";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363544";"F";"SANGER: Inhibition of human NCI-H720 cell growth in a cell viability assay.";"Homo sapiens";"121";"122";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H720";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363726";"F";"SANGER: Inhibition of human A375 cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A-375";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1051257";"B";"Binding constant for RET(M918T) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P07949";"M918T"
"CHEMBL2363675";"F";"SANGER: Inhibition of human SUP-T1 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SUP-T1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1062869";"B";"Binding constant for RIPK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2363839";"F";"SANGER: Inhibition of human CGTH-W-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CGTH-W-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363831";"F";"SANGER: Inhibition of human no-11 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"no-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1060185";"B";"Binding constant for CHEK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1044652";"B";"Binding constant for DAPK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2363568";"F";"SANGER: Inhibition of human OCI-AML2 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OCI-AML2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1062844";"B";"Binding constant for MAP3K4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051348";"B";"Binding constant for PAK7/PAK5 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051303";"B";"Binding constant for PCTK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063807";"B";"Binding constant for NEK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060190";"B";"Binding constant for EGFR(G719S) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P00533";"G719S"
"CHEMBL1062833";"B";"Binding constant for AURKA kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061077";"B";"Binding constant for KIT(V559D) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P10721";"V559D"
"CHEMBL2219108";"B";"Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219286";"B";"Millipore: Percentage of residual kinase activity of STK4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219059";"B";"Millipore: Percentage of residual kinase activity of ERBB4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219050";"B";"Millipore: Percentage of residual kinase activity of EPHB1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218964";"B";"Millipore: Percentage of residual kinase activity of BRSK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218989";"B";"Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219262";"B";"Millipore: Percentage of residual kinase activity of MAP2K1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219292";"B";"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219021";"B";"Millipore: Percentage of residual kinase activity of DAPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218985";"B";"Millipore: Percentage of residual kinase activity of CDK9 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219093";"B";"Millipore: Percentage of residual kinase activity of GRK7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219068";"B";"Millipore: Percentage of residual kinase activity of FGFR4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219263";"B";"Millipore: Percentage of residual kinase activity of MELK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219026";"B";"Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219057";"B";"Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219072";"B";"Millipore: Percentage of residual kinase activity of FES at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219290";"B";"Millipore: Percentage of residual kinase activity of STK24 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219044";"B";"Millipore: Percentage of residual kinase activity of EPHA5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219190";"B";"Millipore: Percentage of residual kinase activity of SRPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219110";"B";"Millipore: Percentage of residual kinase activity of IGF1R at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219027";"B";"Millipore: Percentage of residual kinase activity of DDR2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219098";"B";"Millipore: Percentage of residual kinase activity of HIPK1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219220";"B";"Millipore: Percentage of residual kinase activity of IRAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219034";"B";"Millipore: Percentage of residual kinase activity of EGFR at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219030";"B";"Millipore: Percentage of residual kinase activity of STK17A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219016";"B";"Millipore: Percentage of residual kinase activity of CAMK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 40 mM HEPES pH 7.4, 5 mM CaCl2, 30 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219333";"B";"Millipore: Percentage of residual kinase activity of ZAP70 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219334";"B";"Millipore: Percentage of residual kinase activity of ZAP70 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219024";"B";"Millipore: Percentage of residual kinase activity of DCLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219109";"B";"Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219035";"B";"Millipore: Percentage of residual kinase activity of EGFR at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219060";"B";"Millipore: Percentage of residual kinase activity of PTK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219100";"B";"Millipore: Percentage of residual kinase activity of HIPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219279";"B";"Millipore: Percentage of residual kinase activity of RPS6KA5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2114730";"F";"PubChem BioAssay. Cell Proliferation Assay against the TMD8 Cell Line (Caspase readout at 16 hrs). (Class of assay: confirmatory) ";"";"270";"272";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219391";"B";"Millipore: Percentage of residual kinase activity of PRKACA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2114777";"F";"PubChem BioAssay. Cell Proliferation Assay against a hMSC Cell Line. (Class of assay: confirmatory) ";"";"271";"272";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2218990";"B";"Millipore: Percentage of residual kinase activity of CSNK1G1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219014";"B";"Millipore: Percentage of residual kinase activity of CAMK2D at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL4401422";"B";"Binding affinity to human FLT3 ITD mutant expressed in baculovirus expression system";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4400537";"30742435";"10.1021/acs.jmedchem.8b01714";"2019";"J Med Chem";"62";"2428";"2446";"";"";"";"";"None";"UNDEFINED MUTATION"
"CHEMBL4401421";"B";"Binding affinity to human FLT3 D835H mutant expressed in baculovirus expression system";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4400537";"30742435";"10.1021/acs.jmedchem.8b01714";"2019";"J Med Chem";"62";"2428";"2446";"";"";"";"";"P36888";"D835H"
"CHEMBL1908499";"B";"Binding constant for PIM3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1244458";"B";"Binding affinity to IKK-beta";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244866";"B";"Binding affinity to HPK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244521";"B";"Binding affinity to MLK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244718";"B";"Binding affinity to ADCK4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244504";"B";"Binding affinity to MAST1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244984";"B";"Binding affinity to SRPK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908475";"B";"Binding constant for ACVRL1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1063699";"B";"Binding constant for BMPR1A kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061136";"B";"Binding constant for full-length BRSK2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063700";"B";"Binding constant for full-length CDK7";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908546";"B";"Binding constant for CSNK2A2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908766";"B";"Binding constant for TLK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908476";"B";"Binding constant for BTK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908488";"B";"Binding constant for KIT(V559D) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P10721";"V559D"
"CHEMBL1908551";"B";"Binding constant for FLT4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908720";"B";"Binding constant for HIPK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1244980";"B";"Binding affinity to SLK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244981";"B";"Binding affinity to SNARK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908797";"B";"Binding constant for NLK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908808";"B";"Binding constant for RIOK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908405";"B";"Binding constant for CDC2L1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908661";"B";"Binding constant for DYRK1B kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908751";"B";"Binding constant for MST2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908625";"B";"Binding constant for CDKL2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908631";"B";"Binding constant for FLT3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908669";"B";"Binding constant for MTOR kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908708";"B";"Binding constant for FGR kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908748";"B";"Binding constant for PRKCQ kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908811";"B";"Binding constant for GSK3A kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908839";"B";"Binding constant for TSSK1B kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908423";"B";"Binding constant for HIPK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908444";"B";"Binding constant for SgK110 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908817";"B";"Binding constant for EPHA8 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908717";"B";"Binding constant for ITK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908428";"B";"Binding constant for CAMK2G kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908620";"B";"Binding constant for MAPKAPK5 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908835";"B";"Binding constant for STK33 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908445";"B";"Binding constant for EPHA6 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908700";"B";"Binding constant for EGFR(L858R) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00533";"L858R"
"CHEMBL1908758";"B";"Binding constant for MAP4K5 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1061186";"B";"Binding constant for SYK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051314";"B";"Binding constant for TGFBR1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051286";"B";"Binding constant for EGFR(L861Q) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P00533";"L861Q"
"CHEMBL1245020";"B";"Binding affinity to ULK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244865";"B";"Binding affinity to HIPK4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244764";"B";"Binding affinity to CDKL2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244502";"B";"Binding affinity to MARK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244964";"B";"Binding affinity to RPS6KA1(Kin.Dom.1-N-terminal)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244465";"B";"Binding affinity to JH1 catalytic domain JAK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244496";"B";"Binding affinity to MAP4K4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244860";"B";"Binding affinity to GSK3B";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244698";"B";"Inhibition of FLT3 autophosphorylation in human RS4-11 cells after 2 hrs by electrochemiluminescence assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"RS4-11";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244700";"T";"Toxicity against human A375 cells after 72 hrs by cell titer-blue assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A-375";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244837";"B";"Binding affinity to FES";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244510";"B";"Binding affinity to MELK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244926";"B";"Binding affinity to PIP5K2B";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244801";"B";"Binding affinity to EGFR";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244979";"B";"Binding affinity to SIK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244542";"B";"Binding affinity to NIM1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245005";"B";"Binding affinity to TLK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244820";"B";"Binding affinity to EPHB1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244548";"B";"Binding affinity to p38-gamma";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245013";"B";"Binding affinity to TSSK1B";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244735";"B";"Binding affinity to BMPR1A";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244516";"B";"Binding affinity to MKNK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244954";"B";"Binding affinity to RET V804M mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P07949";"V804M"
"CHEMBL1244983";"B";"Binding affinity to SRMS";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908416";"B";"Binding constant for GRK7 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908623";"B";"Binding constant for RIOK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908645";"B";"Binding constant for CSK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908762";"B";"Binding constant for CIT kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1062840";"B";"Binding constant for FGFR1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244554";"B";"Binding affinity to PAK7";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244806";"B";"Binding affinity to EGFR L747-S752del, P753S mutant";"";"7";"7";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219005";"B";"Millipore: Percentage of residual kinase activity of CLK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219046";"B";"Millipore: Percentage of residual kinase activity of EPHA7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219296";"B";"Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219025";"B";"Millipore: Percentage of residual kinase activity of DCLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218948";"B";"Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1245014";"B";"Binding affinity to TTK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL4375143";"F";"Antiproliferative activity against human K562 cells measured after 72 hrs by Celltiter-Glo assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL4373701";"31361136";"10.1021/acs.jnatprod.9b00468";"2019";"J Nat Prod";"82";"2279";"2290";"";"";"";"";"";""
"CHEMBL1959130";"F";"Cytotoxicity against human MV4-11 cells assessed as decrease in IC50 after 72 hrs in presence of 20% human serum";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL1955771";"22221201";"10.1021/jm201198w";"2012";"J Med Chem";"55";"725";"734";"";"";"";"";"";""
"CHEMBL1244996";"B";"Binding affinity to TAOK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244966";"B";"Binding affinity to RPS6KA2(Kin.Dom.1-N-terminal)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244746";"B";"Binding affinity to CAMK1D";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244472";"B";"Binding affinity to KIT";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908487";"B";"Binding constant for KIT(L576P) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P10721";"L576P"
"CHEMBL1245006";"B";"Binding affinity to TNIK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244810";"B";"Binding affinity to EGFR L861Q mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00533";"L861Q"
"CHEMBL1244969";"B";"Binding affinity to RPS6KA4(Kin.Dom.1-N-terminal)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244750";"B";"Binding affinity to CAMK2D";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244802";"B";"Binding affinity to EGFR E746-A750del mutant";"";"7";"7";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244476";"B";"Binding affinity to KIT V559D,T670I mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P10721";"V559D,T670I"
"CHEMBL1244939";"B";"Binding affinity to PRKCQ";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244733";"B";"Binding affinity to BIKE";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244921";"B";"Binding affinity to PIK4CB";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244771";"B";"Binding affinity to CLK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244527";"B";"Binding affinity to MST3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244545";"B";"Binding affinity to p38-alpha";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244547";"B";"Binding affinity to p38-delta";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244961";"B";"Binding affinity to ROCK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2363820";"F";"SANGER: Inhibition of human VA-ES-BJ cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"VA-ES-BJ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363571";"F";"SANGER: Inhibition of human OE33 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OE33";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363607";"F";"SANGER: Inhibition of human RPMI-6666 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RPMI-6666";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363629";"F";"SANGER: Inhibition of human SCLC-21H cell growth in a cell viability assay.";"Homo sapiens";"76";"77";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SCLC-21H";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363511";"F";"SANGER: Inhibition of human NCI-H2196 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2196";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363601";"F";"SANGER: Inhibition of human RKO cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RKO";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363747";"F";"SANGER: Inhibition of human BB30-HNC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BB30-HNC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363843";"F";"SANGER: Inhibition of human CHP-212 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CHP-212";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363169";"F";"SANGER: Inhibition of human D-392MG cell growth in a cell viability assay.";"Homo sapiens";"113";"114";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-392MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363578";"F";"SANGER: Inhibition of human OVCAR-5 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OVCAR-5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363234";"F";"SANGER: Inhibition of human G-401 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"G-401";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219360";"B";"Millipore: Percentage of residual kinase activity of PAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218953";"B";"Millipore: Percentage of residual kinase activity of AURKC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219001";"B";"Millipore: Percentage of residual kinase activity of CSNK2A2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 20 mM HEPES pH 7.6, 0.15 M NaCl, 0.1 mM EDTA, 5 mM DTT, 0.1% Triton X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218950";"B";"Millipore: Percentage of residual kinase activity of AURKB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219195";"B";"Millipore: Percentage of residual kinase activity of SYK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219338";"B";"Millipore: Percentage of residual kinase activity of RAF1 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219237";"B";"Millipore: Percentage of residual kinase activity of KDR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219033";"B";"Millipore: Percentage of residual kinase activity of DYRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219056";"B";"Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219084";"B";"Millipore: Percentage of residual kinase activity of FYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219213";"B";"Millipore: Percentage of residual kinase activity of IKBKB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3991690";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"236";"236";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991905";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991684";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991855";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991831";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991637";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991724";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"179";"179";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991860";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991611";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"223";"223";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL4768827";"B";"Inhibition of FLT3 (unknown origin)";"Homo sapiens";"6";"6";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4765285";"32272419";"10.1016/j.ejmech.2020.112205";"2020";"Eur J Med Chem";"195";"112205";"112205";"";"";"";"";"";""
"CHEMBL2219038";"B";"Millipore: Percentage of residual kinase activity of EPHA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219191";"B";"Millipore: Percentage of residual kinase activity of STK33 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219309";"B";"Millipore: Percentage of residual kinase activity of TSSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219395";"B";"Millipore: Percentage of residual kinase activity of AKT2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219000";"B";"Millipore: Percentage of residual kinase activity of CSNK2A2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 20 mM HEPES pH 7.6, 0.15 M NaCl, 0.1 mM EDTA, 5 mM DTT, 0.1% Triton X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218966";"B";"Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219146";"B";"Millipore: Percentage of residual kinase activity of PRKX at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1060238";"B";"Binding constant for full-length BTK";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL4379639";"B";"Inhibition of FLT3 ITD/D835Y double mutant in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"BaF3";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL1062867";"B";"Binding constant for PRKR kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061093";"B";"Binding constant for PTK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060188";"B";"Binding constant for DCAMKL3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060199";"B";"Binding constant for MAP3K5 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061921";"B";"Binding constant for PAK6 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051302";"B";"Binding constant for MARK4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051280";"B";"Binding constant for AKT3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063707";"B";"Binding constant for EPHA7 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063708";"B";"Binding constant for EPHA8 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062865";"B";"Binding constant for PRKCD kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051349";"B";"Binding constant for full-length PCTK2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061906";"B";"Binding constant for full-length MEK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060250";"B";"Binding constant for full-length MEK3";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2219061";"B";"Millipore: Percentage of residual kinase activity of PTK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219306";"B";"Millipore: Percentage of residual kinase activity of TLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219194";"B";"Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL4731356";"F";"Growth inhibition of human neoplastic mast cells incubated for 24 to 48 hrs";"Homo sapiens";"3";"3";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Mast cell";"";"CHEMBL4725462";"33214818";"10.1021/acsmedchemlett.0c00202";"2020";"ACS Med Chem Lett";"11";"2087";"2107";"";"";"";"";"";""
"CHEMBL1908408";"B";"Binding constant for STK35 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL2219251";"B";"Millipore: Percentage of residual kinase activity of MAPK3 at 1uM relative to control. Control inhibitor: ERK Inhibitor II at 30.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219107";"B";"Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1051254";"B";"Binding constant for PRKCE kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060183";"B";"Binding constant for CAMK2B kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1053760";"B";"Binding constant for full-length DAPK2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060181";"B";"Binding constant for full-length DLK";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063798";"B";"Binding constant for full-length ERK2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061187";"B";"Binding constant for TXK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061188";"B";"Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2219092";"B";"Millipore: Percentage of residual kinase activity of GRK7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219031";"B";"Millipore: Percentage of residual kinase activity of STK17A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219054";"B";"Millipore: Percentage of residual kinase activity of EPHB3 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219321";"B";"Millipore: Percentage of residual kinase activity of ULK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219355";"B";"Millipore: Percentage of residual kinase activity of NLK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1039274";"B";"Binding constant for full-length PKAC-beta";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063703";"B";"Binding constant for full-length CSNK1A1L";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1050829";"B";"Binding constant for full-length CSNK1D";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2219067";"B";"Millipore: Percentage of residual kinase activity of FGFR3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1063704";"B";"Binding constant for full-length CSNK1G2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051266";"B";"Selectivity for FLT3 as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0";"Homo sapiens";"5";"5";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062874";"B";"Binding constant for TNIK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL2219182";"B";"Millipore: Percentage of residual kinase activity of SGK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219066";"B";"Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219319";"B";"Millipore: Percentage of residual kinase activity of TXK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218960";"B";"Millipore: Percentage of residual kinase activity of BLK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219148";"B";"Millipore: Percentage of residual kinase activity of PTK2B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218962";"B";"Millipore: Percentage of residual kinase activity of BMX at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219393";"B";"Millipore: Percentage of residual kinase activity of AKT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219187";"B";"Millipore: Percentage of residual kinase activity of SRPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219345";"B";"Millipore: Percentage of residual kinase activity of MTOR at 1uM relative to control. Control inhibitor: PI-103 at 30.0uM. Buffer: 50 mM HEPES pH 7.5, 1 mM EGTA, 0.01% Tween 20";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219316";"B";"Millipore: Percentage of residual kinase activity of NTRK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219255";"B";"Millipore: Percentage of residual kinase activity of MAPKAPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219159";"B";"Millipore: Percentage of residual kinase activity of ROS1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219350";"B";"Millipore: Percentage of residual kinase activity of RPS6KB1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219174";"B";"Millipore: Percentage of residual kinase activity of MAPK11 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363744";"F";"SANGER: Inhibition of human AU565 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"AU565";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363174";"F";"SANGER: Inhibition of human DB cell growth in a cell viability assay.";"Homo sapiens";"128";"129";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DB";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363225";"F";"SANGER: Inhibition of human EW-18 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-18";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363371";"F";"SANGER: Inhibition of human LB373-MEL-D cell growth in a cell viability assay.";"Homo sapiens";"117";"119";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB373-MEL-D";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363372";"F";"SANGER: Inhibition of human LB647-SCLC cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB647-SCLC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363247";"F";"SANGER: Inhibition of human GR-ST cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GR-ST";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363494";"F";"SANGER: Inhibition of human NCI-H1882 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1882";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363495";"F";"SANGER: Inhibition of human NCI-H1963 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1963";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363145";"F";"SANGER: Inhibition of human COR-L279 cell growth in a cell viability assay.";"Homo sapiens";"76";"77";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COR-L279";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1244849";"B";"Binding affinity to FLT3 K663Q mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P36888";"K663Q"
"CHEMBL1244985";"B";"Binding affinity to SRPK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244809";"B";"Binding affinity to EGFR L858R,T790M mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00533";"L858R,T790M"
"CHEMBL1244751";"B";"Binding affinity to CAMK2G";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244841";"B";"Binding affinity to FGFR3 G697C mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P22607";"G697C"
"CHEMBL1244945";"B";"Binding affinity to PRKR";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL4739795";"B";"Binding affinity to RIOK3 (unknown origin)";"Homo sapiens";"17";"34";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Patent Bioactivity Data";"9606";"";"";"";"";"CHEMBL4739713";"None";"None";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1244723";"B";"Binding affinity to AMPK-alpha1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244822";"B";"Binding affinity to EPHB3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244479";"B";"Binding affinity to LATS2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2363259";"F";"SANGER: Inhibition of human HCC1599 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1599";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363509";"F";"SANGER: Inhibition of human NCI-H2170 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2170";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363658";"F";"SANGER: Inhibition of human SK-OV-3 cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-OV-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1244749";"B";"Binding affinity to CAMK2B";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244520";"B";"Binding affinity to MLK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244525";"B";"Binding affinity to MST1R";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244927";"B";"Binding affinity to PKAC-alpha";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245028";"B";"Binding affinity to YSK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244758";"B";"Binding affinity to CDK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244833";"B";"Binding affinity to ERK8";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908783";"B";"Binding constant for SLK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908415";"B";"Binding constant for PFTAIRE2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908418";"B";"Binding constant for MEK5 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908521";"B";"Binding constant for PIP5K1A kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908575";"B";"Binding constant for PIM1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1244976";"B";"Binding affinity to SgK085";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1061922";"B";"Binding constant for full-length PDPK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051260";"B";"Binding constant for TYRO3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051262";"B";"Binding constant for YES kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061189";"B";"Binding constant for ZAP70 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062830";"B";"Binding constant for ABL1(Q252H) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P00519";"Q252H"
"CHEMBL1057717";"B";"Binding constant for JAK1(Kin.Dom.1/JH2 - pseudokinase) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051258";"B";"Binding constant for full-length RIOK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061183";"B";"Binding constant for full-length p38-gamma";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062829";"B";"Binding constant for ABL1(M351T) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P00519";"M351T"
"CHEMBL1061079";"B";"Binding constant for full-length MEK2";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908733";"B";"Binding constant for PIK3CA kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908514";"B";"Binding constant for MYO3B kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908532";"B";"Binding constant for ERN1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908542";"B";"Binding constant for CDK7 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908465";"B";"Binding constant for SRPK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908528";"B";"Binding constant for CHEK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908579";"B";"Binding constant for PKAC-beta kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL2219289";"B";"Millipore: Percentage of residual kinase activity of STK24 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219359";"B";"Millipore: Percentage of residual kinase activity of PAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219048";"B";"Millipore: Percentage of residual kinase activity of EPHA8 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1908436";"B";"Binding constant for GRK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908836";"B";"Binding constant for SNARK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908640";"B";"Binding constant for ACVR1B kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1244991";"B";"Binding affinity to STK39";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908698";"B";"Binding constant for EGFR(L747-S752del, P753S) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908711";"B";"Binding constant for PRKCE kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908736";"B";"Binding constant for PIK3CA(E545A) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P42336";"E545A"
"CHEMBL1908782";"B";"Binding constant for ULK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908725";"B";"Binding constant for ASK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1061078";"B";"Binding constant for LTK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908770";"B";"Binding constant for SGK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1062846";"B";"Binding constant for NEK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244552";"B";"Binding affinity to PAK4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244696";"B";"Binding affinity to FLT3 catalytic domain by KinomeScan kinase binding assay";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244529";"B";"Binding affinity to MUSK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219011";"B";"Millipore: Percentage of residual kinase activity of CAMK2B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219012";"B";"Millipore: Percentage of residual kinase activity of CAMK2G at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219242";"B";"Millipore: Percentage of residual kinase activity of STK11 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.1% v/v Triton X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1061895";"B";"Binding constant for EPHA4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051259";"B";"Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL3991835";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991836";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991632";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1908522";"B";"Binding constant for BMPR1B kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908535";"B";"Binding constant for ACVR2A kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908815";"B";"Binding constant for CAMK1D kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908637";"B";"Binding constant for FLT3(R834Q) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P36888";"R834Q"
"CHEMBL1908647";"B";"Binding constant for DMPK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908764";"B";"Binding constant for NDR1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908504";"B";"Binding constant for TNK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL3991857";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1908704";"B";"Binding constant for EGFR(T790M) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00533";"T790M"
"CHEMBL3991841";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"228";"228";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991907";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"211";"211";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1908795";"B";"Binding constant for IRAK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908729";"B";"Binding constant for TRKB kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL3991686";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991620";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"231";"231";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991681";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991638";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991604";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991723";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1061934";"B";"Binding constant for TTK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061134";"B";"Binding constant for full-length BMX";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060239";"B";"Binding constant for full-length CAMK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063701";"B";"Binding constant for full-length CDK9";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1050832";"B";"Binding constant for SNF1LK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062783";"B";"Binding constant for PDGFRA kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1037549";"B";"Binding constant for PHKG2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061174";"B";"Binding constant for FLT1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061184";"B";"Binding constant for PIM2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051351";"B";"Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062785";"B";"Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051307";"B";"Binding constant for PAK4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL3991743";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991843";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991902";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1061135";"B";"Binding constant for BRSK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061903";"B";"Binding constant for MAP4K5 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1050834";"B";"Binding constant for full-length CSNK1E";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061160";"B";"Binding constant for MYLK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061176";"B";"Binding constant for MAP4K1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062778";"B";"Binding constant for MEK4 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060236";"B";"Binding constant for full-length AURKC";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061159";"B";"Binding constant for PTK6 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060242";"B";"Binding constant for DMPK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061143";"B";"Binding constant for EGFR(E746-A750del) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060235";"B";"Binding constant for ANKK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244704";"B";"Binding affinity to ABL1 F317I mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00519";"F317I"
"CHEMBL1244740";"B";"Binding affinity to BRAF V600E mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P15056";"V600E"
"CHEMBL1051278";"B";"Binding constant for ACVR1B kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061983";"B";"Binding constant for full-length STK33";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051282";"B";"Binding constant for BRAF(V600E) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P15056";"V600E"
"CHEMBL1244511";"B";"Binding affinity to MERTK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1051283";"B";"Binding constant for CDK8 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244847";"B";"Binding affinity to FLT3 D835Y mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P36888";"D835Y"
"CHEMBL1060251";"B";"Binding constant for MRCKA kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1245008";"B";"Binding affinity to TNK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1051290";"B";"Binding constant for MRCKB kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060261";"B";"Binding constant for PRKCH kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244958";"B";"Binding affinity to RIPK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244934";"B";"Binding affinity to PLK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244978";"B";"Binding affinity to SIK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1062831";"B";"Binding constant for ADCK3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062843";"B";"Binding constant for LATS1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061930";"B";"Binding constant for TIE1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061154";"B";"Binding constant for PKMYT1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061137";"B";"Binding constant for CAMK2G kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062836";"B";"Binding constant for CAMKK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060178";"B";"Binding constant for CAMK1G kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244930";"B";"Binding affinity to PKN1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244942";"B";"Binding affinity to PRKD3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244784";"B";"Binding affinity to CTK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL3214970";"F";"PubChem BioAssay. qHTS Assay for Identifying Gametocytocidal Compounds.   (Class of assay: confirmatory) ";"";"1095";"1204";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1245004";"B";"Binding affinity to TLK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244553";"B";"Binding affinity to PAK6";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244825";"B";"Binding affinity to ERBB2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244538";"B";"Binding affinity to NEK5";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1787527";"B";"Binding affinity to human KIT D816V mutant incubated for 1 hr by kinase binding assay";"Homo sapiens";"39";"39";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1782045";"21429632";"10.1016/j.ejmech.2011.02.057";"2011";"Eur J Med Chem";"46";"2043";"2057";"";"";"";"";"P10721";"D816V"
"CHEMBL2219367";"B";"Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1060195";"B";"Binding constant for INSR kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061073";"B";"Binding constant for FLT3(N841I) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P36888";"N841I"
"CHEMBL2219134";"B";"Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2341275";"B";"Binding affinity to human full-length His-tagged Myt1 kinase expressed in HEK293 cells at 10 uM by TR-FRET based binding assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2331380";"22770610";"10.1016/j.ejmech.2012.06.007";"2013";"Eur J Med Chem";"61";"41";"48";"";"";"";"";"";""
"CHEMBL2219370";"B";"Millipore: Percentage of residual kinase activity of PASK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218968";"B";"Millipore: Percentage of residual kinase activity of CDK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219298";"B";"Millipore: Percentage of residual kinase activity of MUSK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219301";"B";"Millipore: Percentage of residual kinase activity of NEK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219105";"B";"Millipore: Percentage of residual kinase activity of GSG2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3595192";"B";"Inhibition of FLT3 ITD heterozygous mutant in human MOLM-13 cells assessed as cell growth inhibition after 72 hrs by MTS assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"MOLM-13";"";"CHEMBL3593229";"26081023";"10.1016/j.ejmech.2015.05.008";"2015";"Eur J Med Chem";"100";"151";"161";"";"";"";"";"";""
"CHEMBL3595191";"B";"Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"Sf9";"";"CHEMBL3593229";"26081023";"10.1016/j.ejmech.2015.05.008";"2015";"Eur J Med Chem";"100";"151";"161";"";"";"";"";"";""
"CHEMBL2219397";"B";"Millipore: Percentage of residual kinase activity of AKT3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363610";"F";"SANGER: Inhibition of human RPMI-8402 cell growth in a cell viability assay.";"Homo sapiens";"76";"77";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RPMI-8402";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219336";"B";"Millipore: Percentage of residual kinase activity of DAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219342";"B";"Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219234";"B";"Millipore: Percentage of residual kinase activity of MAPK9 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363393";"F";"SANGER: Inhibition of human LU-139 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LU-139";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363216";"F";"SANGER: Inhibition of human ES8 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES8";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363513";"F";"SANGER: Inhibition of human NCI-H2228 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2228";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363823";"F";"SANGER: Inhibition of human WM-115 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"WM-115";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363668";"F";"SANGER: Inhibition of human SNU-449 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-449";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363790";"F";"SANGER: Inhibition of human TE-12 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-12";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363309";"F";"SANGER: Inhibition of human IGROV-1 cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IGROV-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363408";"F";"SANGER: Inhibition of human MDA-MB-231 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-231";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363413";"F";"SANGER: Inhibition of human ME-180 cell growth in a cell viability assay.";"Homo sapiens";"90";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ME-180";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363448";"F";"SANGER: Inhibition of human Mewo cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MeWo";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363451";"F";"SANGER: Inhibition of human NB1 cell growth in a cell viability assay.";"Homo sapiens";"76";"77";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1061902";"B";"Binding constant for full-length LIMK1";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061175";"B";"Binding constant for INSRR kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063808";"B";"Binding constant for full-length NEK7";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062835";"B";"Binding constant for CAMK2A kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060184";"B";"Binding constant for CDC2L1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062847";"B";"Binding constant for NEK5 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063737";"B";"Binding constant for PAK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063796";"B";"Binding constant for EGFR(L747-E749del, A750P) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063797";"B";"Binding constant for EGFR(L747-S752del, P753S) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051284";"B";"Binding constant for full-length CSNK1G3";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061900";"B";"Binding constant for full-length GSK3A";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL3991731";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"236";"236";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991697";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"240";"240";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991693";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991840";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"241";"241";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1060175";"B";"Binding constant for AMPK-alpha1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061068";"B";"Binding constant for EGFR(G719C) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"P00533";"G719C"
"CHEMBL1060177";"B";"Binding constant for ARK5 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062784";"B";"Binding constant for full-length PIP5K2B";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061158";"B";"Binding constant for full-length PTK2B";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060240";"B";"Binding constant for full-length CLK3";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061931";"B";"Binding constant for TLK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051355";"B";"Binding constant for TNK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061090";"B";"Binding constant for MAPKAPK2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061924";"B";"Binding constant for full-length RIOK3";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061091";"B";"Binding constant for full-length p38-alpha";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062864";"B";"Binding constant for full-length p38-beta";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1060248";"B";"Binding constant for GCN2(Kin.Dom.2,S808G) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"Q9P2K8";"S808G"
"CHEMBL1067460";"F";"Inhibition of mouse GM-CSF-stimulated cell proliferation of growth factor dependent mouse FDC-P1 cells expressing human FMS after 48 hrs by resazurin dye reduction assay";"Mus musculus";"5";"10";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"FDC-P1";"";"CHEMBL1157596";"20156689";"10.1016/j.bmc.2010.01.056";"2010";"Bioorg Med Chem";"18";"1789";"1797";"";"";"";"";"";""
"CHEMBL1067461";"U";"Selectivity index, ratio of IC50 for mouse GM-CSF-stimulated proliferation of mouse FDC-P1 cells expressing human FMS to IC50 for human FMS-mediated mouse FDC-P1 cells proliferation in presence of human CSF1";"";"5";"5";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"FDC-P1";"";"CHEMBL1157596";"20156689";"10.1016/j.bmc.2010.01.056";"2010";"Bioorg Med Chem";"18";"1789";"1797";"";"";"";"";"";""
"CHEMBL1060247";"B";"Binding constant for FRK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062779";"B";"Binding constant for full-length PAK3";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051340";"B";"Binding constant for PIM3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051308";"B";"Binding constant for PIM1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061925";"B";"Binding constant for ROS1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062786";"B";"Binding constant for RPS6KA2(Kin.Dom.2 - C-terminal) kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908501";"B";"Binding constant for ERBB2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908406";"B";"Binding constant for MYLK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908722";"B";"Binding constant for MAK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908823";"B";"Binding constant for TAOK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908454";"B";"Binding constant for PKMYT1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908580";"B";"Binding constant for PRKCI kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908607";"B";"Binding constant for TTK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908716";"B";"Binding constant for AKT3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908824";"B";"Binding constant for RSK3(Kin.Dom.1-N-terminal) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL4731357";"F";"Induction of apoptosis in human HMC-1.2 cells by flow cytometry";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HMC-1.2";"";"CHEMBL4725462";"33214818";"10.1021/acsmedchemlett.0c00202";"2020";"ACS Med Chem Lett";"11";"2087";"2107";"";"";"";"";"";""
"CHEMBL1908471";"B";"Binding constant for QSK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908691";"B";"Binding constant for AKT1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1244813";"B";"Binding affinity to EPHA2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244519";"B";"Binding affinity to MLK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244968";"B";"Binding affinity to RPS6KA3(Kin.Dom.1-N-terminal)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244781";"B";"Binding affinity to CSNK1G3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244517";"B";"Binding affinity to MKNK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908630";"B";"Binding constant for PLK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1244558";"B";"Binding affinity to PDGFRA";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244537";"B";"Binding affinity to NEK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244970";"B";"Binding affinity to RPS6KA4(Kin.Dom.2-C-terminal)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908677";"B";"Binding constant for ABL1(F317I)-phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"F317I"
"CHEMBL1244977";"B";"Binding affinity to SgK110";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244701";"B";"Binding affinity to AAK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244732";"B";"Binding affinity to AXL";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244814";"B";"Binding affinity to EPHA3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908509";"B";"Binding constant for SBK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908793";"B";"Binding constant for STK36 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908767";"B";"Binding constant for PFTK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908775";"B";"Binding constant for SRPK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1245017";"B";"Binding affinity to TYK2(JH2domain-pseudokinase)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2363223";"F";"SANGER: Inhibition of human EW-13 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-13";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363439";"F";"SANGER: Inhibition of human MONO-MAC-6 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MONO-MAC-6";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363231";"F";"SANGER: Inhibition of human FADU cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"FaDu";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363569";"F";"SANGER: Inhibition of human OCUB-M cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OCUB-M";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363619";"F";"SANGER: Inhibition of human S-117 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"S-117";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363720";"F";"SANGER: Inhibition of human A172 cell growth in a cell viability assay.";"Homo sapiens";"89";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A 172";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363722";"F";"SANGER: Inhibition of human A2058 cell growth in a cell viability assay.";"Homo sapiens";"95";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A2058";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363758";"F";"SANGER: Inhibition of human BHY cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BHY";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1908443";"B";"Binding constant for WEE2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908578";"B";"Binding constant for PKAC-alpha kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908614";"B";"Binding constant for MST3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908674";"B";"Binding constant for OSR1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1244710";"B";"Binding affinity to ABL1 Y253F mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00519";"Y253F"
"CHEMBL1244932";"B";"Binding affinity to PLK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908563";"B";"Binding constant for MLK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908789";"B";"Binding constant for NDR2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908467";"B";"Binding constant for CAMK2D kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908570";"B";"Binding constant for PAK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908434";"B";"Binding constant for EPHA5 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908536";"B";"Binding constant for AKT2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908462";"B";"Binding constant for TRKC kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908550";"B";"Binding constant for FLT1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908584";"B";"Binding constant for ERK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908447";"B";"Binding constant for PRP4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908703";"B";"Binding constant for EGFR(S752-I759del) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908407";"B";"Binding constant for SRMS kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908695";"B";"Binding constant for EGFR(G719C) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00533";"G719C"
"CHEMBL1908813";"B";"Binding constant for ADCK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908421";"B";"Binding constant for TAK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908482";"B";"Binding constant for JAK3(JH1domain-catalytic) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908523";"B";"Binding constant for BMPR2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908577";"B";"Binding constant for PIK4CB kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908582";"B";"Binding constant for ERK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1037550";"B";"Binding constant for TESK1 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908459";"B";"Binding constant for DLK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL2219007";"B";"Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1908616";"B";"Binding constant for AURKA kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL4379573";"F";"Antiproliferative activity against human GISTT1 cells harboring heterozygous deletion mutation at C-kit exon 11 assessed as cell growth inhibition after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"GISTT1";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL1245025";"B";"Binding affinity to YANK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244719";"B";"Binding affinity to AKT1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244796";"B";"Binding affinity to DRAK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244797";"B";"Binding affinity to DRAK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244799";"B";"Binding affinity to DYRK1B";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244818";"B";"Binding affinity to EPHA7";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244481";"B";"Binding affinity to LIMK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244495";"B";"Binding affinity to MAP4K3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244497";"B";"Binding affinity to MAP4K5";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244518";"B";"Binding affinity to MLCK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244535";"B";"Binding affinity to NDR2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244572";"B";"Binding affinity to PIK3CA H1047L mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P42336";"H1047L"
"CHEMBL1244466";"B";"Binding affinity to JAK1 JH2 domain";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2363666";"F";"SANGER: Inhibition of human SNU-387 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-387";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363326";"F";"SANGER: Inhibition of human K5 cell growth in a cell viability assay.";"Homo sapiens";"128";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"K5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991829";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991810";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1244499";"B";"Binding affinity to MAPKAPK5";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL3991872";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991764";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"234";"234";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991747";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991849";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1908424";"B";"Binding constant for FYN kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908537";"B";"Binding constant for AXL kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL3991909";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1908412";"B";"Binding constant for ERK8 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908712";"B";"Binding constant for ROCK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908731";"B";"Binding constant for PDGFRA kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL3595193";"B";"Inhibition of FLT3 ITD homozygous mutant in human MV4-11 cells assessed as cell growth inhibition after 72 hrs by MTS assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL3593229";"26081023";"10.1016/j.ejmech.2015.05.008";"2015";"Eur J Med Chem";"100";"151";"161";"";"";"";"";"";""
"CHEMBL3991676";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1048161";"B";"Binding constant for FGFR2 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063698";"B";"Binding constant for BIKE kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1063791";"B";"Binding constant for BLK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1043736";"B";"Binding constant for full-length CDK3";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1062871";"B";"Binding constant for SNARK kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061927";"B";"Binding constant for SRC kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1050840";"B";"Binding constant for FGR kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1061898";"B";"Binding constant for FLT3 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244555";"B";"Binding affinity to PCTK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244938";"B";"Binding affinity to PRKCH";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245009";"B";"Binding affinity to TNNI3K";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908525";"B";"Binding constant for CDK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908556";"B";"Binding constant for JAK1(JH1domain-catalytic) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908559";"B";"Binding constant for LYN kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908547";"B";"Binding constant for DDR1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908527";"B";"Binding constant for CDK9 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908701";"B";"Binding constant for EGFR(L858R,T790M) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00533";"L858R,T790M"
"CHEMBL1908818";"B";"Binding constant for RET kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908730";"B";"Binding constant for PCTK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908702";"B";"Binding constant for EGFR(L861Q) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00533";"L861Q"
"CHEMBL1908710";"B";"Binding constant for LCK kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908735";"B";"Binding constant for PIK3CA(E542K) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P42336";"E542K"
"CHEMBL1908788";"B";"Binding constant for MAST1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908809";"B";"Binding constant for YANK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908831";"B";"Binding constant for PIP5K2C kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908493";"B";"Binding constant for MET(Y1235D) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P08581";"Y1235D"
"CHEMBL1908512";"B";"Binding constant for ERBB4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908739";"B";"Binding constant for PIK3CA(H1047Y) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P42336";"H1047Y"
"CHEMBL1908772";"B";"Binding constant for INSRR kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908800";"B";"Binding constant for MST4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908438";"B";"Binding constant for LRRK2(G2019S) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"Q5S007";"G2019S"
"CHEMBL1908802";"B";"Binding constant for EPHB2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908591";"B";"Binding constant for MEK3 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908611";"B";"Binding constant for WEE1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908657";"B";"Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908659";"B";"Binding constant for ASK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908715";"B";"Binding constant for YES kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908732";"B";"Binding constant for PHKG1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908757";"B";"Binding constant for CAMKK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908441";"B";"Binding constant for ZAP70 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908502";"B";"Binding constant for RSK3(Kin.Dom.2-C-terminal) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908615";"B";"Binding constant for DYRK2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908636";"B";"Binding constant for FLT3(N841I) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P36888";"N841I"
"CHEMBL1908651";"B";"Binding constant for EPHB1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908676";"B";"Binding constant for ABL1(F317I)-non phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"F317I"
"CHEMBL1062872";"B";"Binding constant for SRMS kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1051353";"B";"Binding constant for STK16 kinase domain";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1908474";"B";"Binding constant for DDR2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908470";"B";"Binding constant for AMPK-alpha1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908506";"B";"Binding constant for MYLK4 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908665";"B";"Binding constant for DRAK1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908678";"B";"Binding constant for ABL1(F317L)-non phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"F317L"
"CHEMBL1908557";"B";"Binding constant for VEGFR2 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL2363752";"F";"SANGER: Inhibition of human BCPAP cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BCPAP";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363482";"F";"SANGER: Inhibition of human NCI-H1651 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1651";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363246";"F";"SANGER: Inhibition of human GP5d cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GP5d";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363338";"F";"SANGER: Inhibition of human KM12 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KM12";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363282";"F";"SANGER: Inhibition of human HO-1-N-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HO-1-N-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363420";"F";"SANGER: Inhibition of human MFH-ino cell growth in a cell viability assay.";"Homo sapiens";"109";"110";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MFH-ino";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363848";"F";"SANGER: Inhibition of human COLO-678 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-678";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363740";"F";"SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"AM-38";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363184";"F";"SANGER: Inhibition of human DMS-79 cell growth in a cell viability assay.";"Homo sapiens";"104";"105";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DMS-79";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363776";"F";"SANGER: Inhibition of human CAKI-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAKI-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363646";"F";"SANGER: Inhibition of human SK-MEL-24 cell growth in a cell viability assay.";"Homo sapiens";"94";"94";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MEL-24";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363687";"F";"SANGER: Inhibition of human SW626 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW626";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363283";"F";"SANGER: Inhibition of human HOP-62 cell growth in a cell viability assay.";"Homo sapiens";"117";"119";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HOP-62";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363697";"F";"SANGER: Inhibition of human SW982 cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW982";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363357";"F";"SANGER: Inhibition of human KYSE-270 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-270";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363429";"F";"SANGER: Inhibition of human MKN28 cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MKN-28";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363299";"F";"SANGER: Inhibition of human HUTU-80 cell growth in a cell viability assay.";"Homo sapiens";"116";"118";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HUTU-80";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363621";"F";"SANGER: Inhibition of human SBC-1 cell growth in a cell viability assay.";"Homo sapiens";"124";"125";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SBC-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363522";"F";"SANGER: Inhibition of human NCI-H28 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H28";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363431";"F";"SANGER: Inhibition of human MKN7 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MKN-7";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363229";"F";"SANGER: Inhibition of human EW-7 cell growth in a cell viability assay.";"Homo sapiens";"46";"47";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-7";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363266";"F";"SANGER: Inhibition of human HCC38 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC38";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363586";"F";"SANGER: Inhibition of human PANC-10-05 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Panc1005";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363624";"F";"SANGER: Inhibition of human SCC-25 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SCC-25";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363165";"F";"SANGER: Inhibition of human D-247MG cell growth in a cell viability assay.";"Homo sapiens";"113";"115";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-247MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363370";"F";"SANGER: Inhibition of human LB2518-MEL cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB2518-MEL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363608";"F";"SANGER: Inhibition of human RPMI-7951 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RPMI-7951";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363644";"F";"SANGER: Inhibition of human SK-MEL-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MEL-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363799";"F";"SANGER: Inhibition of human TGBC24TKB cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TGBC24TKB";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363316";"F";"SANGER: Inhibition of human IST-SL2 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IST-SL2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363500";"F";"SANGER: Inhibition of human NCI-H2030 cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2030";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363382";"F";"SANGER: Inhibition of human LN-405 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LN-405";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219275";"B";"Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244561";"B";"Binding affinity to PFTAIRE2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244713";"B";"Binding affinity to ACVR1B";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244739";"B";"Binding affinity to BRAF";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244859";"B";"Binding affinity to GSK3A";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244532";"B";"Binding affinity to MYO3A";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244571";"B";"Binding affinity to PIK3CA E545K mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P42336";"E545K"
"CHEMBL2219152";"B";"Millipore: Percentage of residual kinase activity of ROCK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219177";"B";"Millipore: Percentage of residual kinase activity of MAPK13 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219200";"B";"Millipore: Percentage of residual kinase activity of TAOK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219184";"B";"Millipore: Percentage of residual kinase activity of SGK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219185";"B";"Millipore: Percentage of residual kinase activity of SIK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2089642";"B";"Inhibition of STK32B at 10 uM by luciferase assay";"";"5";"5";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL2086354";"22257127";"10.1021/jm201265f";"2012";"J Med Chem";"55";"1526";"1537";"";"";"";"";"";""
"CHEMBL2218984";"B";"Millipore: Percentage of residual kinase activity of CDK9 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219045";"B";"Millipore: Percentage of residual kinase activity of EPHA5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219250";"B";"Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219270";"B";"Millipore: Percentage of residual kinase activity of MAP2K7 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218959";"B";"Millipore: Percentage of residual kinase activity of BTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219058";"B";"Millipore: Percentage of residual kinase activity of ERBB4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219330";"B";"Millipore: Percentage of residual kinase activity of WNK3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219170";"B";"Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219015";"B";"Millipore: Percentage of residual kinase activity of CAMK2D at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219101";"B";"Millipore: Percentage of residual kinase activity of HIPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218997";"B";"Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219036";"B";"Millipore: Percentage of residual kinase activity of EPHA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363751";"F";"SANGER: Inhibition of human BC-3 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BC-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1068697";"B";"Inhibition of CSF1-stimulated human FMS autophosphorylation expressed in growth factor dependent mouse FDC-P1 cells assessed as phosphorylated receptor level at 500 nM relative to control by Western blot";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"FDC-P1";"";"CHEMBL1157596";"20156689";"10.1016/j.bmc.2010.01.056";"2010";"Bioorg Med Chem";"18";"1789";"1797";"";"";"";"";"";""
"CHEMBL1244915";"B";"Binding affinity to PIK3CA H1047Y mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P42336";"H1047Y"
"CHEMBL1244705";"B";"Binding affinity to ABL1 F317L mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00519";"F317L"
"CHEMBL1244567";"B";"Binding affinity to PIK3CA";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244776";"B";"Binding affinity to CSNK1A1L";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244916";"B";"Binding affinity to PIK3CA M1043I mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P42336";"M1043I"
"CHEMBL1244965";"B";"Binding affinity to RPS6KA1(Kin.Dom.2-C-terminal)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244808";"B";"Binding affinity to EGFR L858R mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00533";"L858R"
"CHEMBL1244992";"B";"Binding affinity to SYK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1063803";"B";"Binding constant for full-length MELK";"Homo sapiens";"38";"38";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1150977";"18183025";"10.1038/nbt1358";"2008";"Nat Biotechnol";"26";"127";"132";"";"";"";"";"";""
"CHEMBL1244562";"B";"Binding affinity to PFTK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244962";"B";"Binding affinity to ROCK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244711";"B";"Binding affinity to ABL2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244541";"B";"Binding affinity to NEK9";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244557";"B";"Binding affinity to PCTK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244702";"B";"Binding affinity to ABL1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244785";"B";"Binding affinity to DAPK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244786";"B";"Binding affinity to DAPK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244836";"B";"Binding affinity to FER";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244716";"B";"Binding affinity to ACVRL1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244566";"B";"Binding affinity to PIK3C2G";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245002";"B";"Binding affinity to TIE1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244743";"B";"Binding affinity to BRSK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244770";"B";"Binding affinity to CLK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244840";"B";"Binding affinity to FGFR3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244852";"B";"Binding affinity to FRK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245027";"B";"Binding affinity to YES";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244765";"B";"Binding affinity to CDKL3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244775";"B";"Binding affinity to CSK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244949";"B";"Binding affinity to QSK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244546";"B";"Binding affinity to p38-beta";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244987";"B";"Binding affinity to STK16";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1908450";"B";"Binding constant for PKNB(M.tuberculosis) kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL2219268";"B";"Millipore: Percentage of residual kinase activity of MAP2K6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol, 0.1 mM Na3VO4, 1 mg/mL BSA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219284";"B";"Millipore: Percentage of residual kinase activity of SRPK3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219354";"B";"Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219373";"B";"Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219239";"B";"Millipore: Percentage of residual kinase activity of LIMK1 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218998";"B";"Millipore: Percentage of residual kinase activity of CSNK2A1 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 20 mM HEPES pH 7.6, 0.15 M NaCl, 0.1 mM EDTA, 5 mM DTT, 0.1% Triton X-100";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218979";"B";"Millipore: Percentage of residual kinase activity of CDK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219051";"B";"Millipore: Percentage of residual kinase activity of EPHB1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219074";"B";"Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219288";"B";"Millipore: Percentage of residual kinase activity of STK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219374";"B";"Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244501";"B";"Binding affinity to MARK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244937";"B";"Binding affinity to PRKCE";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244523";"B";"Binding affinity to MRCKB";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244953";"B";"Binding affinity to RET(V804L)";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P07949";"V804L"
"CHEMBL1244500";"B";"Binding affinity to MARK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2218975";"B";"Millipore: Percentage of residual kinase activity of CDK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218999";"B";"Millipore: Percentage of residual kinase activity of CSNK2A1 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 20 mM HEPES pH 7.6, 0.15 M NaCl, 0.1 mM EDTA, 5 mM DTT, 0.1% Triton X-100";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219023";"B";"Millipore: Percentage of residual kinase activity of DAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219172";"B";"Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1067459";"B";"Inhibition of human FMS expressed in growth factor dependent mouse FDC-P1 cells assessed as inhibition of FMS-mediated cell proliferation in presence human CSF1 after 48 hrs by resazurin dye reduction assay";"Homo sapiens";"5";"10";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"FDC-P1";"";"CHEMBL1157596";"20156689";"10.1016/j.bmc.2010.01.056";"2010";"Bioorg Med Chem";"18";"1789";"1797";"";"";"";"";"";""
"CHEMBL1068700";"B";"Inhibition of CSF1-stimulated human FMS autophosphorylation expressed in growth factor dependent mouse FDC-P1 cells relative to control by Western blot";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"FDC-P1";"";"CHEMBL1157596";"20156689";"10.1016/j.bmc.2010.01.056";"2010";"Bioorg Med Chem";"18";"1789";"1797";"";"";"";"";"";""
"CHEMBL1244563";"B";"Binding affinity to PHKG1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244846";"B";"Binding affinity to FLT3 D835H mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P36888";"D835H"
"CHEMBL2218967";"B";"Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219314";"B";"Millipore: Percentage of residual kinase activity of TEK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219310";"B";"Millipore: Percentage of residual kinase activity of TSSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219086";"B";"Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219037";"B";"Millipore: Percentage of residual kinase activity of EPHA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219077";"B";"Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219078";"B";"Millipore: Percentage of residual kinase activity of FLT3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219229";"B";"Millipore: Percentage of residual kinase activity of JAK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219230";"B";"Millipore: Percentage of residual kinase activity of JAK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1244737";"B";"Binding affinity to BMPR2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219302";"B";"Millipore: Percentage of residual kinase activity of NEK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL1245030";"B";"Binding affinity to ZAK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244722";"B";"Binding affinity to ALK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244509";"B";"Binding affinity to MEK6";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL3991631";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"240";"240";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991699";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"169";"169";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991701";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991751";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991668";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"222";"222";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991920";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991783";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"215";"215";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991787";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991766";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991806";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991760";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991761";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991762";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991763";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"238";"238";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991741";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991892";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363214";"F";"SANGER: Inhibition of human ES6 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES6";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363194";"F";"SANGER: Inhibition of human DoTc2-4510 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DoTc2-4510";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363518";"F";"SANGER: Inhibition of human NCI-H2347 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2347";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363558";"F";"SANGER: Inhibition of human NKM-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NKM-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363356";"F";"SANGER: Inhibition of human KYSE-180 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-180";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363559";"F";"SANGER: Inhibition of human NMC-G1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NMC-G1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363594";"F";"SANGER: Inhibition of human RCC10RGB cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RCC10RGB";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363655";"F";"SANGER: Inhibition of human SK-N-DZ cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-N-DZ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363656";"F";"SANGER: Inhibition of human SK-N-FI cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-N-FI";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363327";"F";"SANGER: Inhibition of human KALS-1 cell growth in a cell viability assay.";"Homo sapiens";"133";"135";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KALS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363360";"F";"SANGER: Inhibition of human KYSE-510 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-510";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363248";"F";"SANGER: Inhibition of human GT3TKB cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GT3TKB";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363781";"F";"SANGER: Inhibition of human CAL-33 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-33";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363164";"F";"SANGER: Inhibition of human ChaGo-K-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ChaGo-K-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363689";"F";"SANGER: Inhibition of human SW756 cell growth in a cell viability assay.";"Homo sapiens";"96";"97";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW756";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363447";"F";"SANGER: Inhibition of human MZ7-mel cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MZ7-mel";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215013";"F";"PubChem BioAssay. qHTS for small molecule inhibitors of Yes1 kinase: Primary Screen.   (Class of assay: confirmatory) ";"";"502";"515";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363171";"F";"SANGER: Inhibition of human D-502MG cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-502MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363766";"F";"SANGER: Inhibition of human BV-173 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BV-173";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363181";"F";"SANGER: Inhibition of human DMS-153 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DMS-153";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363144";"F";"SANGER: Inhibition of human COR-L23 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COR-L23";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363397";"F";"SANGER: Inhibition of human LXF-289 cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LXF-289 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363353";"F";"SANGER: Inhibition of human KY821 cell growth in a cell viability assay.";"Homo sapiens";"120";"121";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KY821";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363400";"F";"SANGER: Inhibition of human M14 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"M14";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363627";"F";"SANGER: Inhibition of human SCC-9 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SCC-9";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363508";"F";"SANGER: Inhibition of human NCI-H2141 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2141";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363552";"F";"SANGER: Inhibition of human NCI-N87 cell growth in a cell viability assay.";"Homo sapiens";"105";"106";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-N87";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363584";"F";"SANGER: Inhibition of human PANC-03-27 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PANC-03-27";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363667";"F";"SANGER: Inhibition of human SNU-423 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-423";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363406";"F";"SANGER: Inhibition of human MDA-MB-157 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-157";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363478";"F";"SANGER: Inhibition of human NCI-H1618 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1618";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363791";"F";"SANGER: Inhibition of human TE-15 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-15";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363432";"F";"SANGER: Inhibition of human ML-2 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ML-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363464";"F";"SANGER: Inhibition of human NCI-H1092 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1092";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363268";"F";"SANGER: Inhibition of human HCE-4 cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCE-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363296";"F";"SANGER: Inhibition of human HT-3 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363384";"F";"SANGER: Inhibition of human LOUCY cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LOUCY";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363332";"F";"SANGER: Inhibition of human KE-37 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KE-37";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363279";"F";"SANGER: Inhibition of human HLE cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HLE";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363458";"F";"SANGER: Inhibition of human NB6 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB6";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991716";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL4360629";"F";"Cytotoxicity against mouse Ba/F3 FLT3-ITD cells";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL4359824";"31207462";"10.1016/j.ejmech.2019.06.002";"2019";"Eur J Med Chem";"178";"468";"483";"";"";"";"";"";""
"CHEMBL2363240";"F";"SANGER: Inhibition of human GCT cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GCT";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4495582";"F";"SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate";"Severe acute respiratory syndrome coronavirus 2";"7218";"8702";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"SARS-CoV-2 Screening Data 2020-21";"2697049";"";"";"";"";"CHEMBL4495564";"None";"10.6019/CHEMBL4495564";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1244753";"B";"Binding affinity to CAMKK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244868";"B";"Binding affinity to ICK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244514";"B";"Binding affinity to MET Y1235D mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P08581";"Y1235D"
"CHEMBL1244956";"B";"Binding affinity to RIOK2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244756";"B";"Binding affinity to CDC2L2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244540";"B";"Binding affinity to NEK7";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL4379635";"F";"Antiproliferative activity against human RS4:11 expressing native FLT3 assessed as cell growth inhibition after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RS4-11";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL1244736";"B";"Binding affinity to BMPR1B";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244920";"B";"Binding affinity to PIK3CG";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219141";"B";"Millipore: Percentage of residual kinase activity of PLK1 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 20 mM DTT";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219073";"B";"Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363641";"F";"SANGER: Inhibition of human SK-HEP-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-HEP-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363642";"F";"SANGER: Inhibition of human SK-LMS-1 cell growth in a cell viability assay.";"Homo sapiens";"116";"118";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-LMS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3885761";"B";"Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument";"Homo sapiens";"27";"84";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"K4DD Project";"9606";"";"";"";"";"CHEMBL3885741";"None";"10.6019/CHEMBL3885741";"None";"None";"None";"None";"None";"standard_type:assay_method standard_relation:None standard_value:None standard_units:None comments:None | standard_type:data_collection_rate standard_relation:None standard_value:10.0 standard_units:Hz comments:None | standard_type:fitting_model standard_relation:None standard_value:None standard_units:None comments:None | standard_type:fitting_parameter_mass_transfer standard_relation:None standard_value:None standard_units:None comments:None | standard_type:fitting_parameter_offset standard_relation:None standard_value:None standard_units:None comments:None | standard_type:fitting_parameter_rmax standard_relation:None standard_value:None standard_units:None comments:None | standard_type:immobilization_buffer_composition standard_relation:None standard_value:None standard_units:None comments:None | standard_type:immobilization_chip_used standard_relation:None standard_value:None standard_units:None comments:None | standard_type:immobilization_contact_time standard_relation:= standard_value:600.0 standard_units:s comments:None | standard_type:immobilization_flow_rate standard_relation:= standard_value:10.0 standard_units:uL/min comments:None | standard_type:immobilization_method standard_relation:None standard_value:None standard_units:None comments:None | standard_type:immobilization_ph standard_relation:= standard_value:7.4 standard_units:None comments:None | standard_type:immobilization_temperature standard_relation:= standard_value:25.0 standard_units:degree C comments:None | standard_type:instrument standard_relation:None standard_value:None standard_units:None comments:None | standard_type:preparation_reference_surface standard_relation:None standard_value:None standard_units:None comments:None | standard_type:protein_modification standard_relation:None standard_value:None standard_units:None comments:None | standard_type:protein_molecular_weight standard_relation:= standard_value:32869.7 standard_units:kDa comments:None | standard_type:protein_mutation_type standard_relation:None standard_value:None standard_units:None comments:None | standard_type:reference1_fraction_active standard_relation:= standard_value:29.7 standard_units:% comments:None | standard_type:reference1_molecular_weight standard_relation:= standard_value:469.94 standard_units:g/mol comments:None | standard_type:reference1_name standard_relation:None standard_value:None standard_units:None comments:None | standard_type:reference1_ru_max standard_relation:= standard_value:7.683 standard_units:RU comments:None | standard_type:regeneration_contact_time standard_relation:= standard_value:30.0 standard_units:s comments:None | standard_type:regeneration_ph standard_relation:= standard_value:9.0 standard_units:None comments:None | standard_type:regeneration_solution standard_relation:None standard_value:None standard_units:None comments:None | standard_type:regeneration_stabilization_period standard_relation:= standard_value:0.0 standard_units:s comments:None | standard_type:sample_association_time standard_relation:= standard_value:60.0 standard_units:s comments:None | standard_type:sample_buffer_composition standard_relation:None standard_value:None standard_units:None comments:None | standard_type:sample_dissociation_time standard_relation:= standard_value:1000.0 standard_units:s comments:None | standard_type:sample_flow_rate standard_relation:= standard_value:100.0 standard_units:uL/min comments:None | standard_type:sample_ph standard_relation:= standard_value:7.4 standard_units:None comments:None | standard_type:sample_temperature standard_relation:= standard_value:25.0 standard_units:degree C comments:None | standard_type:setup_type standard_relation:None standard_value:None standard_units:None comments:None | standard_type:software standard_relation:None standard_value:None standard_units:None comments:None | standard_type:target_density standard_relation:= standard_value:15089.2 standard_units:RU comments:None";"";"";"";"";""
"CHEMBL2363276";"F";"SANGER: Inhibition of human HGC-27 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HGC-27";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3595190";"B";"Inhibition of recombinant GST-tagged VEGFR2 kinase domain (V789 to V1356) (unknown origin) expressed in insect Sf9 cells using polyGlu4:Tyr peptide as substrate after 120 mins by Kinase-Glo assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"Sf9";"";"CHEMBL3593229";"26081023";"10.1016/j.ejmech.2015.05.008";"2015";"Eur J Med Chem";"100";"151";"161";"";"";"";"";"";""
"CHEMBL1244869";"B";"Binding affinity to IGF1R";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244464";"B";"Binding affinity to ITK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244564";"B";"Binding affinity to PHKG2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244971";"B";"Binding affinity to RPS6KA5(Kin.Dom.1-N-terminal)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1245029";"B";"Binding affinity to YSK4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244811";"B";"Binding affinity to EGFR S752-I759del mutant";"";"7";"7";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244950";"B";"Binding affinity to RAF1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244706";"B";"Binding affinity to ABL1 H396P mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P00519";"H396P"
"CHEMBL1244752";"B";"Binding affinity to CAMK4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244759";"B";"Binding affinity to CDK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244807";"B";"Binding affinity to EGFR L747-T751del, Sins mutant";"";"7";"7";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244842";"B";"Binding affinity to FGFR4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244854";"B";"Binding affinity to GAK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244457";"B";"Binding affinity to IKK-alpha";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244791";"B";"Binding affinity to DDR1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244480";"B";"Binding affinity to LCK";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244486";"B";"Binding affinity to LYN";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244493";"B";"Binding affinity to MAP3K4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL3991652";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991654";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1908825";"B";"Binding constant for CSNK1G1 kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"";""
"CHEMBL1908675";"B";"Binding constant for ABL1(E255K)-phosphorylated kinase domain";"";"72";"72";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1908390";"22037378";"10.1038/nbt.1990";"2011";"Nat Biotechnol";"29";"1046";"1051";"";"";"";"";"P00519";"E255K"
"CHEMBL2219053";"B";"Millipore: Percentage of residual kinase activity of EPHB2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219249";"B";"Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219244";"B";"Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219085";"B";"Millipore: Percentage of residual kinase activity of FYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363773";"F";"SANGER: Inhibition of human C3A cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"C3A";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363723";"F";"SANGER: Inhibition of human A253 cell growth in a cell viability assay.";"Homo sapiens";"110";"112";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A253 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363774";"F";"SANGER: Inhibition of human C8166 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"C8166";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363575";"F";"SANGER: Inhibition of human OS-RC-2 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OS-RC-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363202";"F";"SANGER: Inhibition of human EFM-19 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EFM-19";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363837";"F";"SANGER: Inhibition of human CESS cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CESS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363192";"F";"SANGER: Inhibition of human Daudi cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Daudi";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363770";"F";"SANGER: Inhibition of human C-4-II cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"C-4-II";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363670";"F";"SANGER: Inhibition of human SNU-C1 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-C1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363825";"F";"SANGER: Inhibition of human YAPC cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"YAPC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363696";"F";"SANGER: Inhibition of human SW962 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW 962";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363582";"F";"SANGER: Inhibition of human P31-FUJ cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"P31-FUJ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363395";"F";"SANGER: Inhibition of human LU-65 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Lu-65";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363721";"F";"SANGER: Inhibition of human A204 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A204";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363598";"F";"SANGER: Inhibition of human RERF-LC-MS cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RERF-LC-MS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363570";"F";"SANGER: Inhibition of human OE19 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OE19";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363800";"F";"SANGER: Inhibition of human TGW cell growth in a cell viability assay.";"Homo sapiens";"100";"101";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TGW";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363402";"F";"SANGER: Inhibition of human MC-IXC cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MC-IXC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363154";"F";"SANGER: Inhibition of human CW-2 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CW-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363803";"F";"SANGER: Inhibition of human TK10 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TK-10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363502";"F";"SANGER: Inhibition of human NCI-H2081 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2081";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363160";"F";"SANGER: Inhibition of human Calu-6 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Calu-6";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363715";"F";"SANGER: Inhibition of human 786-0 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"786-0";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363555";"F";"SANGER: Inhibition of human NCI-SNU-5 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363337";"F";"SANGER: Inhibition of human KM-H2 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KM-H2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363403";"F";"SANGER: Inhibition of human MC116 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MC116";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363241";"F";"SANGER: Inhibition of human GDM-1 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GDM-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363787";"F";"SANGER: Inhibition of human CAL-85-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-85-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363724";"F";"SANGER: Inhibition of human A2780 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A2780";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363239";"F";"SANGER: Inhibition of human GCIY cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GCIY";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363563";"F";"SANGER: Inhibition of human NUGC-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NUGC-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363596";"F";"SANGER: Inhibition of human RD cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RD";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363664";"F";"SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.";"Homo sapiens";"132";"134";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNB-75";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363193";"F";"SANGER: Inhibition of human Detroit562 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Detroit 562";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363416";"F";"SANGER: Inhibition of human MEL-JUSO cell growth in a cell viability assay.";"Homo sapiens";"81";"82";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MEL-JUSO";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363452";"F";"SANGER: Inhibition of human NB10 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363490";"F";"SANGER: Inhibition of human NCI-H1792 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1792";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363341";"F";"SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KNS-42";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219346";"B";"Millipore: Percentage of residual kinase activity of MTOR at 10uM relative to control. Control inhibitor: PI-103 at 30.0uM. Buffer: 50 mM HEPES pH 7.5, 1 mM EGTA, 0.01% Tween 20";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219384";"B";"Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219385";"B";"Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219197";"B";"Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219188";"B";"Millipore: Percentage of residual kinase activity of SRPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219307";"B";"Millipore: Percentage of residual kinase activity of TSSK1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219332";"B";"Millipore: Percentage of residual kinase activity of YES1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL4375144";"F";"Antiproliferative activity against human HL60 cells measured after 72 hrs by Celltiter-Glo assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL4373701";"31361136";"10.1021/acs.jnatprod.9b00468";"2019";"J Nat Prod";"82";"2279";"2290";"";"";"";"";"";""
"CHEMBL2363291";"F";"SANGER: Inhibition of human HT-1080 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT-1080";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363574";"F";"SANGER: Inhibition of human OPM-2 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OPM-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363411";"F";"SANGER: Inhibition of human MDA-MB-453 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-453";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219366";"B";"Millipore: Percentage of residual kinase activity of PAK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219201";"B";"Millipore: Percentage of residual kinase activity of TAOK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3991721";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2219173";"B";"Millipore: Percentage of residual kinase activity of MAPK11 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363683";"F";"SANGER: Inhibition of human SW1783 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1783";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991886";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"241";"241";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363695";"F";"SANGER: Inhibition of human SW954 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW 954";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363405";"F";"SANGER: Inhibition of human MDA-MB-134-VI cell growth in a cell viability assay.";"Homo sapiens";"76";"77";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-134-VI";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363640";"F";"SANGER: Inhibition of human SK-CO-1 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-CO-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363681";"F";"SANGER: Inhibition of human SW1573 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1573";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363407";"F";"SANGER: Inhibition of human MDA-MB-175-VII cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-175-VII";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363453";"F";"SANGER: Inhibition of human NB12 cell growth in a cell viability assay.";"Homo sapiens";"113";"114";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB12";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363764";"F";"SANGER: Inhibition of human BT-474 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BT-474";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363182";"F";"SANGER: Inhibition of human DMS-273 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DMS-273";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363778";"F";"SANGER: Inhibition of human CAL-12T cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-12T";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363850";"F";"SANGER: Inhibition of human COLO-680N cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-680N";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991696";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991711";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"240";"240";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991641";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991874";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1244999";"B";"Binding affinity to TESK1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL3991875";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1244715";"B";"Binding affinity to ACVR2B";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2363549";"F";"SANGER: Inhibition of human NCI-H82 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H82";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991796";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363275";"F";"SANGER: Inhibition of human HEL cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HEL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4672390";"B";"Inhibition of N-His6-tagged human AspH (315-755) expressed in Escherichia coli BL21 (DE3) using 1 uM hFX-CP as substrate mixture with 3 uM 2OG, 100 uM L-ascorbic acid and high 20 uM FAS incubated for 35 mins by MS analysis";"Homo sapiens";"12";"12";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4665871";"33069066";"10.1016/j.bmc.2020.115675";"2020";"Bioorg Med Chem";"28";"115675";"115675";"";"";"";"";"";""
"CHEMBL2219040";"B";"Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219132";"B";"Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219133";"B";"Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219136";"B";"Millipore: Percentage of residual kinase activity of PIM1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219305";"B";"Millipore: Percentage of residual kinase activity of TLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363554";"F";"SANGER: Inhibition of human NCI-SNU-16 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-16";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363203";"F";"SANGER: Inhibition of human EFO-21 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EFO-21";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363626";"F";"SANGER: Inhibition of human SCC-4 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SCC-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363205";"F";"SANGER: Inhibition of human EGI-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EGI-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363443";"F";"SANGER: Inhibition of human MSTO-211H cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MSTO-211H";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363404";"F";"SANGER: Inhibition of human MCF7 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MCF7";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363441";"F";"SANGER: Inhibition of human MRK-nu-1 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MRK-nu-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363477";"F";"SANGER: Inhibition of human NCI-H1581 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1581";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363523";"F";"SANGER: Inhibition of human NCI-H292 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H292";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363680";"F";"SANGER: Inhibition of human SW1463 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1463";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363659";"F";"SANGER: Inhibition of human SK-PN-DW cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-PN-DW";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363699";"F";"SANGER: Inhibition of human SiHa cell growth in a cell viability assay.";"Homo sapiens";"96";"97";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SiHa";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363700";"F";"SANGER: Inhibition of human T-24 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"T-24";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363300";"F";"SANGER: Inhibition of human Hs-578-T cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Hs-578-T";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363620";"F";"SANGER: Inhibition of human SAS cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SAS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363755";"F";"SANGER: Inhibition of human BFTC-905 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BFTC-905";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363534";"F";"SANGER: Inhibition of human NCI-H524 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H524";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363609";"F";"SANGER: Inhibition of human RPMI-8226 cell growth in a cell viability assay.";"Homo sapiens";"128";"129";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RPMI-8226";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363350";"F";"SANGER: Inhibition of human KU-19-19 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KU-19-19";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363830";"F";"SANGER: Inhibition of human no-10 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"no-10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363233";"F";"SANGER: Inhibition of human G-361 cell growth in a cell viability assay.";"Homo sapiens";"78";"79";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"G-361";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363804";"F";"SANGER: Inhibition of human TT cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TT";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363459";"F";"SANGER: Inhibition of human NB69 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB69";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363577";"F";"SANGER: Inhibition of human OVCAR-4 cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OVCAR-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363761";"F";"SANGER: Inhibition of human BOKU cell growth in a cell viability assay.";"Homo sapiens";"63";"63";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BOKU";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363840";"F";"SANGER: Inhibition of human CHL-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CHL-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363841";"F";"SANGER: Inhibition of human CHP-126 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CHP-126";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219166";"B";"Millipore: Percentage of residual kinase activity of RPS6KA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219344";"B";"Millipore: Percentage of residual kinase activity of EEF2K at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219337";"B";"Millipore: Percentage of residual kinase activity of RAF1 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219118";"B";"Millipore: Percentage of residual kinase activity of PRKCI at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219331";"B";"Millipore: Percentage of residual kinase activity of YES1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2091244";"B";"Inhibition of PKG1 at 10 uM by luciferase assay";"";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL2086354";"22257127";"10.1021/jm201265f";"2012";"J Med Chem";"55";"1526";"1537";"";"";"";"";"";""
"CHEMBL1245031";"B";"Binding affinity to ZAP70";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2363427";"F";"SANGER: Inhibition of human MIA-PaCa-2 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MIA PaCa-2 ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363158";"F";"SANGER: Inhibition of human Calu-1 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Calu-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363691";"F";"SANGER: Inhibition of human SW837 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW837";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363196";"F";"SANGER: Inhibition of human EB2 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EB2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363213";"F";"SANGER: Inhibition of human ES5 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ES5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363200";"F";"SANGER: Inhibition of human ECC4 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ECC4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363201";"F";"SANGER: Inhibition of human EFE-184 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EFE-184";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363474";"F";"SANGER: Inhibition of human NCI-H1522 cell growth in a cell viability assay.";"Homo sapiens";"76";"77";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1522";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363475";"F";"SANGER: Inhibition of human NCI-H1563 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1563";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363355";"F";"SANGER: Inhibition of human KYSE-150 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-150 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363538";"F";"SANGER: Inhibition of human NCI-H64 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H64";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363794";"F";"SANGER: Inhibition of human TE-6 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-6";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363271";"F";"SANGER: Inhibition of human HCT-15 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCT-15";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363272";"F";"SANGER: Inhibition of human HD-MY-Z cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HD-MY-Z";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363311";"F";"SANGER: Inhibition of human IMR-5 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IMR-5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363344";"F";"SANGER: Inhibition of human KOSC-2 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KOSC-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL5042073";"F";"Antiproliferative activity against human HL-60 cells expressing wild type FLT3 assessed as reduction in cell viability measured after 72 hrs by MTS assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL5038665";"35148084";"10.1021/acs.jmedchem.1c02079";"2022";"J Med Chem";"65";"3597";"3605";"";"";"";"";"";""
"CHEMBL4379574";"F";"Antiproliferative activity against human MOLM13 harboring FLT3-ITD mutant assessed as cell growth inhibition after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLM-13";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL2363547";"F";"SANGER: Inhibition of human NCI-H748 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H748";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363798";"F";"SANGER: Inhibition of human TGBC1TKB cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TGBC1TKB";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363138";"F";"SANGER: Inhibition of human COLO-741 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-741";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363519";"F";"SANGER: Inhibition of human NCI-H2405 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2405";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363313";"F";"SANGER: Inhibition of human IST-MEL1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IST-MEL1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363526";"F";"SANGER: Inhibition of human NCI-H358 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H358";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363560";"F";"SANGER: Inhibition of human NOMO-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NOMO-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363671";"F";"SANGER: Inhibition of human SNU-C2B cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNU-C2B";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363218";"F";"SANGER: Inhibition of human ETK-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ETK-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363219";"F";"SANGER: Inhibition of human EVSA-T cell growth in a cell viability assay.";"Homo sapiens";"85";"87";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EVSA-T";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363253";"F";"SANGER: Inhibition of human HC-1 cell growth in a cell viability assay.";"Homo sapiens";"104";"105";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HC-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363255";"F";"SANGER: Inhibition of human HCC1187 cell growth in a cell viability assay.";"Homo sapiens";"133";"135";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1187";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363565";"F";"SANGER: Inhibition of human OAW-28 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OAW-28";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363636";"F";"SANGER: Inhibition of human SIG-M5 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SIG-M5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363440";"F";"SANGER: Inhibition of human MPP-89 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MPP-89";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4355291";"F";"Antitumour activity in human FLT3 positive AML patient assessed as increase in survival time at 50 mg, po bid for 14 days co-treated with CTX relative to control";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4354798";"30939001";"10.1021/acs.jmedchem.9b00196";"2019";"J Med Chem";"62";"7340";"7382";"";"";"";"";"";""
"CHEMBL4379571";"B";"Inhibition of recombinant N-terminal 6x-His-tagged c-KIT (547 to 935 residues)/(694 to 753 residues deletion) (unknown origin) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate measured after 150 mins in presence of ATP by ADP-glo reagent based luminescence assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"Sf9";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL1244831";"B";"Binding affinity to ERK4";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219161";"B";"Millipore: Percentage of residual kinase activity of TYRO3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219352";"B";"Millipore: Percentage of residual kinase activity of NEK6 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218946";"B";"Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219116";"B";"Millipore: Percentage of residual kinase activity of PRKCQ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219349";"B";"Millipore: Percentage of residual kinase activity of RPS6KB1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219386";"B";"Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219408";"B";"Millipore: Percentage of residual kinase activity of PRKCE at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218942";"B";"Millipore: Percentage of residual kinase activity of PRKCZ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219156";"B";"Millipore: Percentage of residual kinase activity of RET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219180";"B";"Millipore: Percentage of residual kinase activity of SGK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3595194";"F";"Cytotoxicity against FLT3-deficient human U937 cells assessed as cell growth inhibition after 72 hrs by MTS assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL3593229";"26081023";"10.1016/j.ejmech.2015.05.008";"2015";"Eur J Med Chem";"100";"151";"161";"";"";"";"";"";""
"CHEMBL3595196";"B";"Inhibition of wild type BCR/ABL in FLT3 deficient human K562 cells assessed as cell growth inhibition after 72 hrs by MTS assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL3593229";"26081023";"10.1016/j.ejmech.2015.05.008";"2015";"Eur J Med Chem";"100";"151";"161";"";"";"";"";"";""
"CHEMBL3991714";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1244967";"B";"Binding affinity to RPS6KA2(Kin.Dom.2-C-terminal)";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL4315083";"B";"Inhibition of FLT3 ITD mutant (unknown origin)";"Homo sapiens";"1";"1";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4311995";"31614258";"10.1016/j.ejmech.2019.111710";"2019";"Eur J Med Chem";"184";"111710";"111710";"";"";"";"";"None";"UNDEFINED MUTATION"
"CHEMBL2363487";"F";"SANGER: Inhibition of human NCI-H1734 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1734";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363380";"F";"SANGER: Inhibition of human LCLC-97TM1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LCLC-97TM1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4303092";"F";"Overall antiviral activity against SARS-CoV-2 (isolate France/IDF0372/2020) in the Vero E6 cell line at 48 h based on three assays 1) detection of viral RNA by qRT-PCR (targeting the N-gene), 2) plaque assay using lysate 3 days after addition of compound by crystal violet staining 3) Cell viability (cytotoxicity) measuring percentage viable Vero E6 cells 48 h after compound addition by AlamarBlue assay.";"Chlorocebus sabaeus";"59";"59";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303773";"32353859";"10.1038/s41586-020-2286-9";"2020";"Nature";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991785";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"233";"233";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991808";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"225";"225";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991830";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991869";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991789";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"227";"227";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991765";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991768";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991915";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"197";"197";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991809";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"188";"188";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991846";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991916";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991871";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991707";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991803";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"237";"237";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991823";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991778";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"238";"238";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991780";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"232";"232";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991746";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991664";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"152";"152";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991749";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991612";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"236";"236";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991698";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"240";"240";"BAO_0000220";"subcellular format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991926";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991879";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2219341";"B";"Millipore: Percentage of residual kinase activity of SRC at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219193";"B";"Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219313";"B";"Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219165";"B";"Millipore: Percentage of residual kinase activity of RPS6KA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219189";"B";"Millipore: Percentage of residual kinase activity of SRPK2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219390";"B";"Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219283";"B";"Millipore: Percentage of residual kinase activity of SRPK3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219406";"B";"Millipore: Percentage of residual kinase activity of PRKCD at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219202";"B";"Millipore: Percentage of residual kinase activity of TAOK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219104";"B";"Millipore: Percentage of residual kinase activity of GSG2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219126";"B";"Millipore: Percentage of residual kinase activity of PRKG1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 uM cGMP";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219127";"B";"Millipore: Percentage of residual kinase activity of MAPKAPK5 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363566";"F";"SANGER: Inhibition of human OAW-42 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OAW-42";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL5042071";"F";"Antiproliferative activity against human ML-1 cells expressing wild type FLT3 assessed as reduction in cell viability measured after 72 hrs by MTS assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"ML-1";"";"CHEMBL5038665";"35148084";"10.1021/acs.jmedchem.1c02079";"2022";"J Med Chem";"65";"3597";"3605";"";"";"";"";"";""
"CHEMBL4731358";"F";"Inhibition of IgE-dependent histamine release in normal human blood basophils";"Homo sapiens";"3";"3";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Basophil";"";"CHEMBL4725462";"33214818";"10.1021/acsmedchemlett.0c00202";"2020";"ACS Med Chem Lett";"11";"2087";"2107";"";"";"";"";"";""
"CHEMBL3991847";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"219";"219";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL5131713";"F";"Antiviral activity against HIV-1";"Human immunodeficiency virus 1";"7";"7";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"11676";"";"";"";"";"CHEMBL5131375";"33539089";"10.1021/acs.jmedchem.0c01467";"2022";"J Med Chem";"65";"893";"921";"";"";"";"";"";""
"CHEMBL2219261";"B";"Millipore: Percentage of residual kinase activity of MAP2K1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 50 mM Tris pH 7.5, 0.2 mM EGTA, 0.1% ?-mercaptoethanol, 0.01% Brij-35";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218988";"B";"Millipore: Percentage of residual kinase activity of CHEK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219241";"B";"Millipore: Percentage of residual kinase activity of STK11 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.1% v/v Triton X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218957";"B";"Millipore: Percentage of residual kinase activity of PTK6 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218980";"B";"Millipore: Percentage of residual kinase activity of CDK6 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219271";"B";"Millipore: Percentage of residual kinase activity of MYLK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219294";"B";"Millipore: Percentage of residual kinase activity of MET at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219069";"B";"Millipore: Percentage of residual kinase activity of FGFR4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218986";"B";"Millipore: Percentage of residual kinase activity of CHEK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219009";"B";"Millipore: Percentage of residual kinase activity of CAMK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219047";"B";"Millipore: Percentage of residual kinase activity of EPHA7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219264";"B";"Millipore: Percentage of residual kinase activity of MELK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219375";"B";"Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219308";"B";"Millipore: Percentage of residual kinase activity of TSSK1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363706";"F";"SANGER: Inhibition of human TCCSUP cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TCC-SUP";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363143";"F";"SANGER: Inhibition of human COR-L105 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COR-L105";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363673";"F";"SANGER: Inhibition of human ST486 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ST486";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363434";"F";"SANGER: Inhibition of human MMAC-SF cell growth in a cell viability assay.";"Homo sapiens";"128";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MMAC-SF";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363813";"F";"SANGER: Inhibition of human U251 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"U-251";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2341276";"B";"Binding affinity to human full-length His-tagged Myt1 kinase expressed in HEK293 cells at 5 uM by TR-FRET based binding assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2331380";"22770610";"10.1016/j.ejmech.2012.06.007";"2013";"Eur J Med Chem";"61";"41";"48";"";"";"";"";"";""
"CHEMBL2219155";"B";"Millipore: Percentage of residual kinase activity of RET at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219157";"B";"Millipore: Percentage of residual kinase activity of MST1R at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219204";"B";"Millipore: Percentage of residual kinase activity of TAOK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363381";"F";"SANGER: Inhibition of human LK-2 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LK-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219317";"B";"Millipore: Percentage of residual kinase activity of NTRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219256";"B";"Millipore: Percentage of residual kinase activity of MAPKAPK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219120";"B";"Millipore: Percentage of residual kinase activity of PRKD1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM HEPES pH 7.4, 0.03% Triton X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219143";"B";"Millipore: Percentage of residual kinase activity of PLK3 at 1uM relative to control. Control inhibitor: Wortmannin at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219144";"B";"Millipore: Percentage of residual kinase activity of PLK3 at 10uM relative to control. Control inhibitor: Wortmannin at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219378";"B";"Millipore: Percentage of residual kinase activity of PRKAA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 200 uM AMP";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219192";"B";"Millipore: Percentage of residual kinase activity of STK33 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219280";"B";"Millipore: Percentage of residual kinase activity of RPS6KA5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219183";"B";"Millipore: Percentage of residual kinase activity of SGK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219379";"B";"Millipore: Percentage of residual kinase activity of PRKAA2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 200 uM AMP";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL4823742";"B";"Selectivity ratio of IC50 for c-KIT (unknown orign) to IC50 for FLT3 (unknown origin)";"";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL4823252";"33797247";"10.1021/acs.jmedchem.0c02247";"2021";"J Med Chem";"64";"4870";"4890";"";"";"";"";"";""
"CHEMBL2219388";"B";"Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219205";"B";"Millipore: Percentage of residual kinase activity of TBK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219324";"B";"Millipore: Percentage of residual kinase activity of ULK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219102";"B";"Millipore: Percentage of residual kinase activity of HIPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219042";"B";"Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219175";"B";"Millipore: Percentage of residual kinase activity of MAPK12 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219198";"B";"Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219318";"B";"Millipore: Percentage of residual kinase activity of NTRK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219402";"B";"Millipore: Percentage of residual kinase activity of PRKCB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219407";"B";"Millipore: Percentage of residual kinase activity of PRKCD at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219131";"B";"Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219281";"B";"Millipore: Percentage of residual kinase activity of RPS6KA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219273";"B";"Millipore: Percentage of residual kinase activity of MAP3K9 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219258";"B";"Millipore: Percentage of residual kinase activity of MAPKAPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219259";"B";"Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219353";"B";"Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219326";"B";"Millipore: Percentage of residual kinase activity of VRK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219224";"B";"Millipore: Percentage of residual kinase activity of INSRR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219142";"B";"Millipore: Percentage of residual kinase activity of PLK1 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 20 mM DTT";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218965";"B";"Millipore: Percentage of residual kinase activity of BRSK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219207";"B";"Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219208";"B";"Millipore: Percentage of residual kinase activity of TGFBR1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219206";"B";"Millipore: Percentage of residual kinase activity of TBK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219062";"B";"Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218994";"B";"Millipore: Percentage of residual kinase activity of CSNK1G3 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219018";"B";"Millipore: Percentage of residual kinase activity of CAMK1D at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM CaCl2, 16 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219065";"B";"Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219199";"B";"Millipore: Percentage of residual kinase activity of TAOK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219401";"B";"Millipore: Percentage of residual kinase activity of PRKCB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219150";"B";"Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219151";"B";"Millipore: Percentage of residual kinase activity of ROCK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363834";"F";"SANGER: Inhibition of human CAS-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219196";"B";"Millipore: Percentage of residual kinase activity of SYK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219312";"B";"Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219335";"B";"Millipore: Percentage of residual kinase activity of DAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219257";"B";"Millipore: Percentage of residual kinase activity of MAPKAPK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363328";"F";"SANGER: Inhibition of human KARPAS-299 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KARPAS-299";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219297";"B";"Millipore: Percentage of residual kinase activity of MUSK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 5 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219121";"B";"Millipore: Percentage of residual kinase activity of PRKD2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219160";"B";"Millipore: Percentage of residual kinase activity of ROS1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219304";"B";"Millipore: Percentage of residual kinase activity of NEK3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363579";"F";"SANGER: Inhibition of human OVCAR-8 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OVCAR-8";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219228";"B";"Millipore: Percentage of residual kinase activity of JAK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363305";"F";"SANGER: Inhibition of human HuP-T3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HuP-T3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363674";"F";"SANGER: Inhibition of human SU-DHL-1 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SU-DHL-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363190";"F";"SANGER: Inhibition of human DV-90 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DV-90";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363753";"F";"SANGER: Inhibition of human BE-13 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BE-13";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363588";"F";"SANGER: Inhibition of human PC-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PC-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363536";"F";"SANGER: Inhibition of human NCI-H596 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H596";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363645";"F";"SANGER: Inhibition of human SK-MEL-2 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MEL-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363320";"F";"SANGER: Inhibition of human JEG-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"JEG-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363318";"F";"SANGER: Inhibition of human J82 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"J82";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363358";"F";"SANGER: Inhibition of human KYSE-410 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-410";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363244";"F";"SANGER: Inhibition of human GMS-10 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GMS-10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363846";"F";"SANGER: Inhibition of human COLO-320-HSR cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-320-HSR";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363623";"F";"SANGER: Inhibition of human SCC-15 cell growth in a cell viability assay.";"Homo sapiens";"133";"135";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SCC-15";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363713";"F";"SANGER: Inhibition of human 697 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"697";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363824";"F";"SANGER: Inhibition of human WSU-NHL cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"WSU-NHL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363267";"F";"SANGER: Inhibition of human HCC70 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC70";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363373";"F";"SANGER: Inhibition of human LB771-HNC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB771-HNC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219083";"B";"Millipore: Percentage of residual kinase activity of CSF1R at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219125";"B";"Millipore: Percentage of residual kinase activity of PRKG1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 uM cGMP";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219164";"B";"Millipore: Percentage of residual kinase activity of RPS6KA1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219138";"B";"Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219186";"B";"Millipore: Percentage of residual kinase activity of SIK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219389";"B";"Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219063";"B";"Millipore: Percentage of residual kinase activity of FGFR1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219080";"B";"Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363525";"F";"SANGER: Inhibition of human NCI-H345 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H345";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363672";"F";"SANGER: Inhibition of human SR cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SR";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363702";"F";"SANGER: Inhibition of human T84 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"T84";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363512";"F";"SANGER: Inhibition of human NCI-H2227 cell growth in a cell viability assay.";"Homo sapiens";"53";"53";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2227";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363564";"F";"SANGER: Inhibition of human NY cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NY";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363368";"F";"SANGER: Inhibition of human LB1047-RCC cell growth in a cell viability assay.";"Homo sapiens";"136";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB1047-RCC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991740";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL4303805";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging";"Homo sapiens";"5616";"5632";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"9606";"";"";"Caco-2";"";"CHEMBL4303101";"None";"10.21203/rs.3.rs-23951/v1";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4379632";"F";"Antiproliferative activity against human U937 assessed as cell growth inhibition after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL2363682";"F";"SANGER: Inhibition of human SW1710 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1710";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991735";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991818";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991820";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"187";"187";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991873";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991895";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991898";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991863";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"229";"229";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991767";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991797";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"228";"228";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL4672387";"B";"Inhibition of N-His6-tagged human AspH (315-755) expressed in Escherichia coli BL21 (DE3) at 20uM using 1 uM hFX-CP as substrate mixture with 3 uM 2OG, 100 uM L-ascorbic acid and 2 uM FAS incubated for 35 mins by MS analysis";"Homo sapiens";"12";"12";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4665871";"33069066";"10.1016/j.bmc.2020.115675";"2020";"Bioorg Med Chem";"28";"115675";"115675";"";"";"";"";"";""
"CHEMBL3991912";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"233";"233";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL4360628";"F";"Cytotoxicity against mouse Ba/F3 FLT3-D835Y cells";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL4359824";"31207462";"10.1016/j.ejmech.2019.06.002";"2019";"Eur J Med Chem";"178";"468";"483";"";"";"";"";"";""
"CHEMBL1244858";"B";"Binding affinity to GRK7";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244844";"B";"Binding affinity to FLT1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL3991773";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991673";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991674";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"238";"238";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991647";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991756";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991646";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"238";"238";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991793";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"217";"217";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL4379637";"A";"Cytotoxicity against mouse BAF3 assessed as cell growth inhibition after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"BaF3";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL2219082";"B";"Millipore: Percentage of residual kinase activity of CSF1R at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218982";"B";"Millipore: Percentage of residual kinase activity of CDK7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219006";"B";"Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3991642";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL4360626";"B";"Binding affinity to N-terminal GST-tagged human FLT3 (563 to 993 residues) cytoplasmic domain expressed in baculovirus infected sf9 cells using poly (Glu, Tyr) 4:1 as substrate in presence of [gamma-33P]-ATP by TopCount method";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"Sf9";"";"CHEMBL4359824";"31207462";"10.1016/j.ejmech.2019.06.002";"2019";"Eur J Med Chem";"178";"468";"483";"";"";"";"";"";""
"CHEMBL3991784";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"220";"220";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991786";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"237";"237";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991682";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"237";"237";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991834";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991870";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991634";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991691";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"239";"239";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991667";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991643";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"231";"231";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991876";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991613";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991880";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363606";"F";"SANGER: Inhibition of human RPMI-2650 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RPMI-2650";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363602";"F";"SANGER: Inhibition of human RL cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4651403";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"Chlorocebus sabaeus";"4309";"8710";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"IMI-CARE SARS-CoV-2 Data";"60711";"";"";"Vero C1008";"";"CHEMBL4651402";"None";"10.6019/CHEMBL4651402";"2021";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991844";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991782";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991828";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"240";"240";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991615";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"238";"238";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991727";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991636";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991658";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"233";"233";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991923";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991917";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991881";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991708";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"237";"237";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991688";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991624";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991906";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991882";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991884";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991602";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2219168";"B";"Millipore: Percentage of residual kinase activity of RPS6KA2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219252";"B";"Millipore: Percentage of residual kinase activity of MAPK3 at 10uM relative to control. Control inhibitor: ERK Inhibitor II at 30.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3815414";"A";"Protein binding in 10% human serum at 100 uM after 3 days";"Homo sapiens";"2";"2";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3638229";"Serum";"";"";"CHEMBL3813655";"27190596";"10.1021/acsmedchemlett.5b00498";"2016";"ACS Med Chem Lett";"7";"476";"481";"";"";"";"";"";""
"CHEMBL4401424";"B";"Binding affinity to human FLT3 ITD/F691L double mutant expressed in baculovirus expression system";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4400537";"30742435";"10.1021/acs.jmedchem.8b01714";"2019";"J Med Chem";"62";"2428";"2446";"";"";"";"";"None";"UNDEFINED MUTATION"
"CHEMBL5131792";"T";"Cytotoxicity against human MDM cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"MDM";"";"CHEMBL5131375";"33539089";"10.1021/acs.jmedchem.0c01467";"2022";"J Med Chem";"65";"893";"921";"";"";"";"";"";""
"CHEMBL4144536";"F";"Induction of apoptosis in human EOL-1 cells assessed as caspase-3 activation at 10 nM after 72 hrs by immunoblotting analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"EOL1";"";"CHEMBL4138271";"29350920";"10.1021/acs.jnatprod.7b01079";"2018";"J Nat Prod";"81";"554";"561";"";"";"";"";"";""
"CHEMBL4144408";"F";"Cytotoxicity against human MOLM13 cells after 72 hrs by MTS assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLM-13";"";"CHEMBL4138271";"29350920";"10.1021/acs.jnatprod.7b01079";"2018";"J Nat Prod";"81";"554";"561";"";"";"";"";"";""
"CHEMBL1244994";"B";"Binding affinity to TAO1";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL1244720";"B";"Binding affinity to AKT2";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219099";"B";"Millipore: Percentage of residual kinase activity of HIPK1 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219002";"B";"Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218958";"B";"Millipore: Percentage of residual kinase activity of BTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219049";"B";"Millipore: Percentage of residual kinase activity of EPHA8 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3562002";"F";"PubChem BioAssay. Immunotoxin (HA22) sensitization/mitigation study. Vehicle arm (PBS).   (Class of assay: confirmatory) ";"";"370";"372";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363308";"F";"SANGER: Inhibition of human IGR-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IGR-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363274";"F";"SANGER: Inhibition of human HEC-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HEC-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363345";"F";"SANGER: Inhibition of human KP-4 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KP-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363378";"F";"SANGER: Inhibition of human LC4-1 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LC4-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363415";"F";"SANGER: Inhibition of human MEL-HO cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MEL-HO";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363614";"F";"SANGER: Inhibition of human RT4 cell growth in a cell viability assay.";"Homo sapiens";"46";"47";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RT-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363615";"F";"SANGER: Inhibition of human RVH-421 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RVH-421";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363616";"F";"SANGER: Inhibition of human RXF393 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RXF 393";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363690";"F";"SANGER: Inhibition of human SW780 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW780";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363807";"F";"SANGER: Inhibition of human U-118-MG cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"U-118-MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363195";"F";"SANGER: Inhibition of human EB-3 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EB-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363593";"F";"SANGER: Inhibition of human QIMR-WIL cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"QIMR-WIL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363709";"F";"SANGER: Inhibition of human 23132-87 cell growth in a cell viability assay.";"Homo sapiens";"78";"79";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"23132-87";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363176";"F";"SANGER: Inhibition of human DEL cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DEL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363492";"F";"SANGER: Inhibition of human NCI-H1838 cell growth in a cell viability assay.";"Homo sapiens";"134";"136";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1838";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363618";"F";"SANGER: Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Ramos-2G6-4C10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363180";"F";"SANGER: Inhibition of human DMS-114 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DMS-114";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363444";"F";"SANGER: Inhibition of human MV-4-11 cell growth in a cell viability assay.";"Homo sapiens";"128";"129";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MV-4-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363617";"F";"SANGER: Inhibition of human Raji cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Raji";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363539";"F";"SANGER: Inhibition of human NCI-H650 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H650";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363435";"F";"SANGER: Inhibition of human MN-60 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MN-60";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363430";"F";"SANGER: Inhibition of human MKN45 cell growth in a cell viability assay.";"Homo sapiens";"89";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MKN-45";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363529";"F";"SANGER: Inhibition of human NCI-H446 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H446";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363637";"F";"SANGER: Inhibition of human SIMA cell growth in a cell viability assay.";"Homo sapiens";"85";"87";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SIMA";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363676";"F";"SANGER: Inhibition of human SW1088 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW1088";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363335";"F";"SANGER: Inhibition of human KINGS-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KINGS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363418";"F";"SANGER: Inhibition of human MFE-280 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MFE-280";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363307";"F";"SANGER: Inhibition of human IA-LM cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IA-LM";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363340";"F";"SANGER: Inhibition of human KMS-12-PE cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KMS-12-PE";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363531";"F";"SANGER: Inhibition of human NCI-H510A cell growth in a cell viability assay.";"Homo sapiens";"104";"105";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H510A";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363832";"F";"SANGER: Inhibition of human CAMA-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAMA-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363714";"F";"SANGER: Inhibition of human 769-P cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"769-P";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363152";"F";"SANGER: Inhibition of human CTB-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CTB-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363708";"F";"SANGER: Inhibition of human 22RV1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CWR22R";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363504";"F";"SANGER: Inhibition of human NCI-H209 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H209";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363303";"F";"SANGER: Inhibition of human HuO-3N1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HuO-3N1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363537";"F";"SANGER: Inhibition of human NCI-H630 cell growth in a cell viability assay.";"Homo sapiens";"74";"75";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H630";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363454";"F";"SANGER: Inhibition of human NB13 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NB13";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363741";"F";"SANGER: Inhibition of human AN3-CA cell growth in a cell viability assay.";"Homo sapiens";"98";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"AN3-CA";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363739";"F";"SANGER: Inhibition of human ALL-PO cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ALL-PO";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363849";"F";"SANGER: Inhibition of human COLO-679 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-679";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363730";"F";"SANGER: Inhibition of human A431 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A-431";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363731";"F";"SANGER: Inhibition of human A498 cell growth in a cell viability assay.";"Homo sapiens";"131";"133";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A498";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363354";"F";"SANGER: Inhibition of human KYSE-140 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-140";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363836";"F";"SANGER: Inhibition of human CCRF-CEM cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CCRF-CEM";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363780";"F";"SANGER: Inhibition of human CAL-27 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-27";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363288";"F";"SANGER: Inhibition of human HSC-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HSC-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363817";"F";"SANGER: Inhibition of human UACC-893 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UACC-893";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363818";"F";"SANGER: Inhibition of human UM-UC-3 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UMUC3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363221";"F";"SANGER: Inhibition of human EW-11 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363401";"F";"SANGER: Inhibition of human MC-CAR cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MC-CAR";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363293";"F";"SANGER: Inhibition of human HT-1376 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT-1376";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363428";"F";"SANGER: Inhibition of human MKN1 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MKN-1 ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363329";"F";"SANGER: Inhibition of human KARPAS-422 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KARPAS-422";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363556";"F";"SANGER: Inhibition of human NEC8 cell growth in a cell viability assay.";"Homo sapiens";"135";"137";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NEC8";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363591";"F";"SANGER: Inhibition of human PLC-PRF-5 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PLC-PRF-5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363510";"F";"SANGER: Inhibition of human NCI-H2171 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2171";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363583";"F";"SANGER: Inhibition of human PA-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PA-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363585";"F";"SANGER: Inhibition of human PANC-08-13 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PANC-08-13";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363622";"F";"SANGER: Inhibition of human SBC-5 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SBC-5";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363657";"F";"SANGER: Inhibition of human SK-NEP-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-NEP-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363587";"F";"SANGER: Inhibition of human PC-14 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PC-14";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363302";"F";"SANGER: Inhibition of human HuH-7 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Huh-7 ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363701";"F";"SANGER: Inhibition of human T47D cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"T47D";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363816";"F";"SANGER: Inhibition of human UACC-812 cell growth in a cell viability assay.";"Homo sapiens";"59";"59";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UACC-812";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363262";"F";"SANGER: Inhibition of human HCC1954 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1954";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363336";"F";"SANGER: Inhibition of human KLE cell growth in a cell viability assay.";"Homo sapiens";"123";"124";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KLE";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363367";"F";"SANGER: Inhibition of human LAN-6 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LAN-6";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363581";"F";"SANGER: Inhibition of human P30-OHK cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"P30-OHK";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363572";"F";"SANGER: Inhibition of human OMC-1 cell growth in a cell viability assay.";"Homo sapiens";"133";"135";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OMC-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363686";"F";"SANGER: Inhibition of human SW620 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW-620";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363351";"F";"SANGER: Inhibition of human KU812 cell growth in a cell viability assay.";"Homo sapiens";"121";"122";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KU812 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363605";"F";"SANGER: Inhibition of human RO82-W-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RO82-W-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363497";"F";"SANGER: Inhibition of human NCI-H1993 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1993";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363785";"F";"SANGER: Inhibition of human CAL-62 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-62";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363688";"F";"SANGER: Inhibition of human SW684 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW684";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363280";"F";"SANGER: Inhibition of human HMV-II cell growth in a cell viability assay.";"Homo sapiens";"89";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HMV-2 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363141";"F";"SANGER: Inhibition of human COLO-824 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-824";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363315";"F";"SANGER: Inhibition of human IST-SL1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IST-SL1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2438983";"B";"Binding affinity to human FLT3";"Homo sapiens";"11";"11";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2434948";"24044867";"10.1021/jm401094t";"2013";"J Med Chem";"56";"8032";"8048";"";"";"";"";"";""
"CHEMBL2363178";"F";"SANGER: Inhibition of human DJM-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DJM-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363760";"F";"SANGER: Inhibition of human BL-70 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BL-70";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363703";"F";"SANGER: Inhibition of human T98G cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"T98G";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363269";"F";"SANGER: Inhibition of human HCE-T cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCE-T";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363306";"F";"SANGER: Inhibition of human HuP-T4 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HuP-T4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363197";"F";"SANGER: Inhibition of human EC-GI-10 cell growth in a cell viability assay.";"Homo sapiens";"112";"114";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EC-GI-10";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363630";"F";"SANGER: Inhibition of human SF126 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SF-126";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363710";"F";"SANGER: Inhibition of human 5637 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"5637";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363175";"F";"SANGER: Inhibition of human DBTRG-05MG cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DBTRG-05MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991750";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363811";"F";"SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.";"Homo sapiens";"137";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"U-87MG ATCC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363217";"F";"SANGER: Inhibition of human ESS-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ESS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363284";"F";"SANGER: Inhibition of human HOP-92 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HOP-92";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363589";"F";"SANGER: Inhibition of human PF-382 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PF-382";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363590";"F";"SANGER: Inhibition of human PFSK-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PFSK-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363822";"F";"SANGER: Inhibition of human VMRC-RCZ cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"VMRC-RCZ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363227";"F";"SANGER: Inhibition of human EW-24 cell growth in a cell viability assay.";"Homo sapiens";"104";"105";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-24";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991748";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363795";"F";"SANGER: Inhibition of human TE-8 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-8";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363237";"F";"SANGER: Inhibition of human GAMG cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GAMG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363186";"F";"SANGER: Inhibition of human DOK cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DOK";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363481";"F";"SANGER: Inhibition of human NCI-H1650 cell growth in a cell viability assay.";"Homo sapiens";"134";"136";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1650";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991628";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"234";"234";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363304";"F";"SANGER: Inhibition of human HuO9 cell growth in a cell viability assay.";"Homo sapiens";"74";"75";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HuO9";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991630";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363718";"F";"SANGER: Inhibition of human 8505C cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"8505C";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991700";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"199";"199";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363738";"F";"SANGER: Inhibition of human AGS cell growth in a cell viability assay.";"Homo sapiens";"95";"96";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"AGS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363146";"F";"SANGER: Inhibition of human COR-L88 cell growth in a cell viability assay.";"Homo sapiens";"121";"122";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COR-L88";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363256";"F";"SANGER: Inhibition of human HCC1395 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1395";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363767";"F";"SANGER: Inhibition of human Becker cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Becker";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363425";"F";"SANGER: Inhibition of human MHH-NB-11 cell growth in a cell viability assay.";"Homo sapiens";"132";"134";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MHH-NB-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363148";"F";"SANGER: Inhibition of human CP66-MEL cell growth in a cell viability assay.";"Homo sapiens";"117";"119";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CP66-MEL";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363287";"F";"SANGER: Inhibition of human HSC-2 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HSC-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991712";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"182";"182";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363323";"F";"SANGER: Inhibition of human JiyoyeP-2003 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"JIYOYE";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363470";"F";"SANGER: Inhibition of human NCI-H1395 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1395";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363359";"F";"SANGER: Inhibition of human KYSE-450 cell growth in a cell viability assay.";"Homo sapiens";"98";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KYSE-450";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363330";"F";"SANGER: Inhibition of human KARPAS-45 cell growth in a cell viability assay.";"Homo sapiens";"124";"125";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KARPAS-45";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363557";"F";"SANGER: Inhibition of human NH-12 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NH-12";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363592";"F";"SANGER: Inhibition of human PSN1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"PSN1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363628";"F";"SANGER: Inhibition of human SCH cell growth in a cell viability assay.";"Homo sapiens";"131";"133";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SCH";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363815";"F";"SANGER: Inhibition of human UACC-62 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UACC-62";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2438984";"B";"Binding affinity to human MLK3";"Homo sapiens";"13";"13";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2434948";"24044867";"10.1021/jm401094t";"2013";"J Med Chem";"56";"8032";"8048";"";"";"";"";"";""
"CHEMBL2363433";"F";"SANGER: Inhibition of human MLMA cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MLMA";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991706";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363759";"F";"SANGER: Inhibition of human BL-41 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BL-41";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363297";"F";"SANGER: Inhibition of human HT55 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT55";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991817";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363394";"F";"SANGER: Inhibition of human LU-165 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LU-165";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363250";"F";"SANGER: Inhibition of human H4 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"H4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363236";"F";"SANGER: Inhibition of human GAK cell growth in a cell viability assay.";"Homo sapiens";"131";"133";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GAK";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363379";"F";"SANGER: Inhibition of human LCLC-103H cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LCLC-103H cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991883";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"241";"241";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991858";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"241";"241";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991885";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"220";"220";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991812";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"215";"215";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991683";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991685";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991607";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"241";"241";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363292";"F";"SANGER: Inhibition of human HT-1197 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT-1197";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363488";"F";"SANGER: Inhibition of human NCI-H1755 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1755";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991614";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363179";"F";"SANGER: Inhibition of human DK-MG cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DK-MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363736";"F";"SANGER: Inhibition of human ACHN cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ACHN";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363665";"F";"SANGER: Inhibition of human SNG-M cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SNG-M";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363599";"F";"SANGER: Inhibition of human RH-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RH-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363611";"F";"SANGER: Inhibition of human RPMI-8866 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RPMI-8866";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363290";"F";"SANGER: Inhibition of human HT cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363678";"F";"SANGER: Inhibition of human SW13 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW13";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363369";"F";"SANGER: Inhibition of human LB2241-RCC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LB2241-RCC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363548";"F";"SANGER: Inhibition of human NCI-H810 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H810";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219320";"B";"Millipore: Percentage of residual kinase activity of TXK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219114";"B";"Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219347";"B";"Millipore: Percentage of residual kinase activity of MTOR at 1uM relative to control. Control inhibitor: Rapamycin at 10.0uM. Buffer: 50 mM HEPES pH 7.5, 1 mM EGTA, 0.01% Tween 20, 10 uM FKBP12";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219162";"B";"Millipore: Percentage of residual kinase activity of TYRO3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219017";"B";"Millipore: Percentage of residual kinase activity of CAMK4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 40 mM HEPES pH 7.4, 5 mM CaCl2, 30 ug/mL calmodulin";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219295";"B";"Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3991758";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363546";"F";"SANGER: Inhibition of human NCI-H747 cell growth in a cell viability assay.";"Homo sapiens";"137";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H747";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363595";"F";"SANGER: Inhibition of human RCM-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RCM-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363462";"F";"SANGER: Inhibition of human NCCIT cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCCIT";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4375145";"A";"Cytotoxicity against human PBMC cells measured after 72 hrs by Celltiter-Glo assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PBMC";"";"CHEMBL4373701";"31361136";"10.1021/acs.jnatprod.9b00468";"2019";"J Nat Prod";"82";"2279";"2290";"";"";"";"";"";""
"CHEMBL2219387";"B";"Millipore: Percentage of residual kinase activity of PDGFRB at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363603";"F";"SANGER: Inhibition of human RL95-2 cell growth in a cell viability assay.";"Homo sapiens";"53";"54";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RL95-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219365";"B";"Millipore: Percentage of residual kinase activity of PAK6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219123";"B";"Millipore: Percentage of residual kinase activity of PRKG1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 uM cGMP";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219149";"B";"Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219322";"B";"Millipore: Percentage of residual kinase activity of ULK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL4303810";"F";"Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits)";"Homo sapiens";"1629";"1637";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"9606";"";"";"HRCE";"";"CHEMBL4303122";"None";"10.1101/2020.04.21.054387";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219231";"B";"Millipore: Percentage of residual kinase activity of MAPK8 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ? -mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2363851";"F";"SANGER: Inhibition of human COLO-684 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-684";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363389";"F";"SANGER: Inhibition of human LS-411N cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LS-411N";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363166";"F";"SANGER: Inhibition of human D-263MG cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-263MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363261";"F";"SANGER: Inhibition of human HCC1937 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC1937";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363331";"F";"SANGER: Inhibition of human KASUMI-1 cell growth in a cell viability assay.";"Homo sapiens";"74";"75";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Kasumi 1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1245026";"B";"Binding affinity to YANK3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2363498";"F";"SANGER: Inhibition of human NCI-H2009 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2009";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363532";"F";"SANGER: Inhibition of human NCI-H520 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H520";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363604";"F";"SANGER: Inhibition of human RMG-I cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RMG-I";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363847";"F";"SANGER: Inhibition of human COLO-668 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-668";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363727";"F";"SANGER: Inhibition of human A388 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A388";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363742";"F";"SANGER: Inhibition of human ARH-77 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ARH-77";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363821";"F";"SANGER: Inhibition of human VM-CUB-1 cell growth in a cell viability assay.";"Homo sapiens";"90";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"VM-CUB-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363643";"F";"SANGER: Inhibition of human SK-LU-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-LU-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363387";"F";"SANGER: Inhibition of human LS-1034 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LS-1034";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363835";"F";"SANGER: Inhibition of human CCF-STTG1 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CCF-STTG1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363147";"F";"SANGER: Inhibition of human CP50-MEL-B cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CP50-MEL-B";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363322";"F";"SANGER: Inhibition of human JVM-3 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"JVM-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363399";"F";"SANGER: Inhibition of human M059J cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"M059J";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363423";"F";"SANGER: Inhibition of human MHH-CALL-2 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MHH-CALL-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363438";"F";"SANGER: Inhibition of human MOLT-4 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MOLT-4";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363786";"F";"SANGER: Inhibition of human CAL-72 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-72";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363844";"F";"SANGER: Inhibition of human CMK cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CMK";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363168";"F";"SANGER: Inhibition of human D-336MG cell growth in a cell viability assay.";"Homo sapiens";"104";"106";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-336MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363576";"F";"SANGER: Inhibition of human OVCAR-3 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"OVCAR-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363208";"F";"SANGER: Inhibition of human EM-2 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EM-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363465";"F";"SANGER: Inhibition of human NCI-H1155 cell growth in a cell viability assay.";"Homo sapiens";"128";"129";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1155";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363467";"F";"SANGER: Inhibition of human NCI-H1299 cell growth in a cell viability assay.";"Homo sapiens";"113";"114";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1299";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363772";"F";"SANGER: Inhibition of human C32 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"C32";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363230";"F";"SANGER: Inhibition of human EoL-1-cell cell growth in a cell viability assay.";"Homo sapiens";"119";"120";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EOL1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363491";"F";"SANGER: Inhibition of human NCI-H1793 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1793";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363777";"F";"SANGER: Inhibition of human CAL-120 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-120";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363263";"F";"SANGER: Inhibition of human HCC2157 cell growth in a cell viability assay.";"Homo sapiens";"102";"103";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCC2157";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363442";"F";"SANGER: Inhibition of human MS-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MS-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363172";"F";"SANGER: Inhibition of human D-542MG cell growth in a cell viability assay.";"Homo sapiens";"93";"94";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"D-542MG";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363285";"F";"SANGER: Inhibition of human HOS cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HOS";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363161";"F";"SANGER: Inhibition of human Caov-3 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Caov-3 cell line";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363321";"F";"SANGER: Inhibition of human JVM-2 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"JVM-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363324";"F";"SANGER: Inhibition of human K-562 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"K562";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363471";"F";"SANGER: Inhibition of human NCI-H1417 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1417";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363426";"F";"SANGER: Inhibition of human MHH-PREB-1 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MHH-PREB-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363472";"F";"SANGER: Inhibition of human NCI-H1436 cell growth in a cell viability assay.";"Homo sapiens";"76";"77";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1436";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363473";"F";"SANGER: Inhibition of human NCI-H1437 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1437";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363516";"F";"SANGER: Inhibition of human NCI-H23 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H23";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363550";"F";"SANGER: Inhibition of human NCI-H838 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H838";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363242";"F";"SANGER: Inhibition of human GI-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GI-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363277";"F";"SANGER: Inhibition of human HH cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HH";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363733";"F";"SANGER: Inhibition of human A673 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A673";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363735";"F";"SANGER: Inhibition of human ABC-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ABC-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363660";"F";"SANGER: Inhibition of human SK-UT-1 cell growth in a cell viability assay.";"Homo sapiens";"128";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-UT-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363775";"F";"SANGER: Inhibition of human CA46 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CA46";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363647";"F";"SANGER: Inhibition of human SK-MEL-28 cell growth in a cell viability assay.";"Homo sapiens";"94";"94";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SK-MEL-28";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363749";"F";"SANGER: Inhibition of human BB65-RCC cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BB65-RCC";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363717";"F";"SANGER: Inhibition of human 8305C cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"8305C";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1244850";"B";"Binding affinity to FLT3 N841I mutant";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"P36888";"N841I"
"CHEMBL4379638";"B";"Inhibition of FLT3 D835Y mutant in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"BaF3";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL4513082";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"Chlorocebus sabaeus";"7218";"17404";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4495565";"None";"10.6019/CHEMBL4495565";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4379633";"F";"Antiproliferative activity against human MV4-11 harboring FLT3-ITD mutant assessed as cell growth inhibition after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL3991752";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991753";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"241";"241";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991795";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"230";"230";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991677";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"237";"237";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL1244826";"B";"Binding affinity to ERBB3";"";"7";"7";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1240346";"19654408";"10.1182/blood-2009-05-222034";"2009";"Blood";"114";"2984";"2992";"";"";"";"";"";""
"CHEMBL2219041";"B";"Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219129";"B";"Millipore: Percentage of residual kinase activity of PKN2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ?-mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219363";"B";"Millipore: Percentage of residual kinase activity of PAK7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219400";"B";"Millipore: Percentage of residual kinase activity of PRKCB at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219117";"B";"Millipore: Percentage of residual kinase activity of PRKCI at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219139";"B";"Millipore: Percentage of residual kinase activity of PIM3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.1% Triton X-100";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL4375142";"F";"Antiproliferative activity against human MV4-11 cells measured after 72 hrs by Celltiter-Glo assay";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL4373701";"31361136";"10.1021/acs.jnatprod.9b00468";"2019";"J Nat Prod";"82";"2279";"2290";"";"";"";"";"";""
"CHEMBL2219368";"B";"Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3991900";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"204";"204";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991850";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991851";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2219351";"B";"Millipore: Percentage of residual kinase activity of NEK6 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219339";"B";"Millipore: Percentage of residual kinase activity of KIT at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3991609";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2219361";"B";"Millipore: Percentage of residual kinase activity of PAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3991890";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991660";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991617";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2219124";"B";"Millipore: Percentage of residual kinase activity of PRKG1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 uM cGMP";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219163";"B";"Millipore: Percentage of residual kinase activity of RPS6KA1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219113";"B";"Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3991864";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"216";"216";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991914";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991794";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991781";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991720";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991722";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991802";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991925";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991837";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991838";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"200";"200";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2219362";"B";"Millipore: Percentage of residual kinase activity of PAK4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2218971";"B";"Millipore: Percentage of residual kinase activity of CDK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219403";"B";"Millipore: Percentage of residual kinase activity of PRKCB at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219128";"B";"Millipore: Percentage of residual kinase activity of MAPKAPK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Na-?-glycerophosphate pH 7.5, 0.1 mM EGTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL4360627";"B";"Inhibition of SKY (unknown origin)";"Homo sapiens";"1";"1";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4359824";"31207462";"10.1016/j.ejmech.2019.06.002";"2019";"Eur J Med Chem";"178";"468";"483";"";"";"";"";"";""
"CHEMBL4303085";"F";"AUC (viral infection %) for SARS-CoV-2 in the Vero E6 cell line at 48 h by immunofluorescence-based assay (detecting the viral NP protein in the nucleus of the Vero E6 cells).";"Chlorocebus sabaeus";"57";"57";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303773";"32353859";"10.1038/s41586-020-2286-9";"2020";"Nature";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991867";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991742";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL2363698";"F";"SANGER: Inhibition of human Saos-2 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SAOS-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363363";"F";"SANGER: Inhibition of human L-363 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"L-363";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363398";"F";"SANGER: Inhibition of human LoVo cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LoVo";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363827";"F";"SANGER: Inhibition of human YKG-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"YKG-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363828";"F";"SANGER: Inhibition of human YT cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"YT";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363228";"F";"SANGER: Inhibition of human EW-3 cell growth in a cell viability assay.";"Homo sapiens";"119";"120";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"EW-3";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363232";"F";"SANGER: Inhibition of human FTC-133 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"FTC-133";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363185";"F";"SANGER: Inhibition of human DOHH-2 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DOHH-2";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363189";"F";"SANGER: Inhibition of human DU-4475 cell growth in a cell viability assay.";"Homo sapiens";"125";"126";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"DU-4475";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363514";"F";"SANGER: Inhibition of human NCI-H226 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H226";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363728";"F";"SANGER: Inhibition of human A4-Fuk cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A4-Fuk";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363707";"F";"SANGER: Inhibition of human TE-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363757";"F";"SANGER: Inhibition of human BHT-101 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BHT-101";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363493";"F";"SANGER: Inhibition of human NCI-H187 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H187";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363796";"F";"SANGER: Inhibition of human TE-9 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"TE-9";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363729";"F";"SANGER: Inhibition of human A427 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"A-427";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363685";"F";"SANGER: Inhibition of human SW48 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SW48";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363801";"F";"SANGER: Inhibition of human THP-1 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"THP-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363388";"F";"SANGER: Inhibition of human LS-123 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LS-123";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363352";"F";"SANGER: Inhibition of human KURAMOCHI cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KURAMOCHI";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363385";"F";"SANGER: Inhibition of human LOXIMVI cell growth in a cell viability assay.";"Homo sapiens";"137";"138";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LOX IMVI ";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363286";"F";"SANGER: Inhibition of human HPAF-II cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HPAF-II";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363437";"F";"SANGER: Inhibition of human MOLT-16 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MOLT-16";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363155";"F";"SANGER: Inhibition of human Ca-Ski cell growth in a cell viability assay.";"Homo sapiens";"90";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"Ca-Ski";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363390";"F";"SANGER: Inhibition of human LS-513 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LS-513";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363245";"F";"SANGER: Inhibition of human GOTO cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GOTO";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363295";"F";"SANGER: Inhibition of human HT-29 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HT-29";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363845";"F";"SANGER: Inhibition of human COLO-205 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"COLO-205";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363517";"F";"SANGER: Inhibition of human NCI-H2342 cell growth in a cell viability assay.";"Homo sapiens";"95";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2342";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363763";"F";"SANGER: Inhibition of human BT-20 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"BT-20";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363507";"F";"SANGER: Inhibition of human NCI-H2126 cell growth in a cell viability assay.";"Homo sapiens";"134";"136";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2126";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363366";"F";"SANGER: Inhibition of human LAMA-84 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"LAMA-84";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363612";"F";"SANGER: Inhibition of human RS4-11 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"RS4-11";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363580";"F";"SANGER: Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay.";"Homo sapiens";"90";"90";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"P12-Ichikawa";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363238";"F";"SANGER: Inhibition of human GB-1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"GB-1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363479";"F";"SANGER: Inhibition of human NCI-H1623 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1623";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363524";"F";"SANGER: Inhibition of human NCI-H322M cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H322M";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363632";"F";"SANGER: Inhibition of human SF295 cell growth in a cell viability assay.";"Homo sapiens";"97";"98";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SF-295";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991842";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991887";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"241";"241";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL4303091";"T";"Selectivity ratio: ratio of AUC (viral infection %) of SARS-CoV-2 in the Vero E6 cell line compared to AUC (cytotoxicity %) of compound against Vero E6 cells by MTT assay.";"";"57";"57";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"SARS-CoV-2 Screening Data 2020-21";"";"";"";"Vero E6";"";"CHEMBL4303773";"32353859";"10.1038/s41586-020-2286-9";"2020";"Nature";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991759";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL4303089";"T";"AUC (cytotoxicity %) of compound against Vero E6 cells by MTT assay.";"Chlorocebus sabaeus";"57";"57";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303773";"32353859";"10.1038/s41586-020-2286-9";"2020";"Nature";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3991730";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3595195";"B";"Inhibition of wild type homozygous FLT3 in human RS4:11 cells assessed as cell growth inhibition after 72 hrs by MTS assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"RS4:11 cell";"";"CHEMBL3593229";"26081023";"10.1016/j.ejmech.2015.05.008";"2015";"Eur J Med Chem";"100";"151";"161";"";"";"";"";"";""
"CHEMBL2219232";"B";"Millipore: Percentage of residual kinase activity of MAPK8 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% ? -mercaptoethanol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219106";"B";"Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219137";"B";"Millipore: Percentage of residual kinase activity of PIM2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219081";"B";"Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3991736";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"242";"242";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991737";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"217";"217";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991775";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"235";"235";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991776";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991777";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991819";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991821";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"224";"224";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991769";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991770";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"238";"238";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991669";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"194";"194";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991671";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"163";"163";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL3991679";"B";"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.";"Homo sapiens";"243";"243";"BAO_0000220";"subcellular format";"9";"9 - Direct single protein target assigned";"";"Kuster lab chemical proteomics drug profiling";"9606";"";"";"K-562, COLO 205, SK-N-BE(2) and MV-4-11";"Cell lysate";"CHEMBL3991601";"29191878";"10.1126/science.aan4368";"2017";"Science";"358";"None";"None";"standard_type:Direct Binder standard_relation:= standard_value:None standard_units:None comments:Is the measured interaction considered due to direct binding to target?";"";"";"";"";""
"CHEMBL4144535";"F";"Induction of apoptosis in human MOLM13 cells assessed as caspase-3 activation at 10 nM after 72 hrs by immunoblotting analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MOLM-13";"";"CHEMBL4138271";"29350920";"10.1021/acs.jnatprod.7b01079";"2018";"J Nat Prod";"81";"554";"561";"";"";"";"";"";""
"CHEMBL4144409";"F";"Cytotoxicity against human EOL-1 cells after 72 hrs by MTS assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"EOL1";"";"CHEMBL4138271";"29350920";"10.1021/acs.jnatprod.7b01079";"2018";"J Nat Prod";"81";"554";"561";"";"";"";"";"";""
"CHEMBL4401425";"B";"Binding affinity to non-auto-inhibited form of wild type human N-terminal GST-tagged FLT3 expressed in baculovirus expression";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4400537";"30742435";"10.1021/acs.jmedchem.8b01714";"2019";"J Med Chem";"62";"2428";"2446";"";"";"";"";"";""
"CHEMBL4731354";"A";"Terminal half life in human plasma";"Homo sapiens";"3";"3";"BAO_0000366";"cell-free format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559721";"Plasma";"";"";"CHEMBL4725462";"33214818";"10.1021/acsmedchemlett.0c00202";"2020";"ACS Med Chem Lett";"11";"2087";"2107";"";"";"";"";"";""
"CHEMBL2219392";"B";"Millipore: Percentage of residual kinase activity of AKT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219325";"B";"Millipore: Percentage of residual kinase activity of VRK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219405";"B";"Millipore: Percentage of residual kinase activity of PRKCG at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL5131747";"B";"Inhibition of AAK1 (unknown origin)";"Homo sapiens";"5";"5";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL5131375";"33539089";"10.1021/acs.jmedchem.0c01467";"2022";"J Med Chem";"65";"893";"921";"";"";"";"";"";""
"CHEMBL2341274";"B";"Binding affinity to human full-length His-tagged Myt1 kinase expressed in HEK293 cells by TR-FRET based binding assay";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2331380";"22770610";"10.1016/j.ejmech.2012.06.007";"2013";"Eur J Med Chem";"61";"41";"48";"";"";"";"";"";""
"CHEMBL2219064";"B";"Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219179";"B";"Millipore: Percentage of residual kinase activity of SGK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219181";"B";"Millipore: Percentage of residual kinase activity of SGK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219203";"B";"Millipore: Percentage of residual kinase activity of TAOK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL2219323";"B";"Millipore: Percentage of residual kinase activity of ULK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL3562034";"F";"PubChem BioAssay. Immunotoxin (SS1P) sensitization/mitigation study. Vehicle arm (DMEM).   (Class of assay: confirmatory) ";"";"344";"346";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2219282";"B";"Millipore: Percentage of residual kinase activity of RPS6KA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA";"Homo sapiens";"158";"158";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2218924";"23398362";"10.1042/bj20121418";"2013";"Biochem J";"451";"313";"328";"";"";"";"";"";""
"CHEMBL4379636";"F";"Antiproliferative activity against human K562 expressing wild type BCR/ABL assessed as cell growth inhibition after 72 hrs by CellTiter 96 AQueous One Solution Cell Proliferation assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL4376836";"31721578";"10.1021/acs.jmedchem.9b01229";"2019";"J Med Chem";"62";"11135";"11150";"";"";"";"";"";""
"CHEMBL2363310";"F";"SANGER: Inhibition of human IM-9 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IM-9";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363312";"F";"SANGER: Inhibition of human IPC-298 cell growth in a cell viability assay.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"IPC-298";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363486";"F";"SANGER: Inhibition of human NCI-H1703 cell growth in a cell viability assay.";"Homo sapiens";"81";"82";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1703";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL5133783";"B";"Inhibition of recombinant GST-tagged human FLT3 expressed in baculovirus expression system by tyrosine kinase assay";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL5131443";"35033885";"10.1016/j.bmc.2021.116596";"2022";"Bioorg Med Chem";"56";"116596";"116596";"";"";"";"";"";""
"CHEMBL2363489";"F";"SANGER: Inhibition of human NCI-H1770 cell growth in a cell viability assay.";"Homo sapiens";"129";"130";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1770";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363270";"F";"SANGER: Inhibition of human HCT-116 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"HCT-116";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363530";"F";"SANGER: Inhibition of human NCI-H460 cell growth in a cell viability assay.";"Homo sapiens";"94";"95";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H460";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363771";"F";"SANGER: Inhibition of human C2BBe1 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"C2BBe1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363501";"F";"SANGER: Inhibition of human NCI-H2052 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H2052";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363543";"F";"SANGER: Inhibition of human NCI-H719 cell growth in a cell viability assay.";"Homo sapiens";"77";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H719";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363745";"F";"SANGER: Inhibition of human AsPC-1 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"ASPC1";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363784";"F";"SANGER: Inhibition of human CAL-54 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"CAL-54";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363533";"F";"SANGER: Inhibition of human NCI-H522 cell growth in a cell viability assay.";"Homo sapiens";"71";"72";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H522";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363410";"F";"SANGER: Inhibition of human MDA-MB-415 cell growth in a cell viability assay.";"Homo sapiens";"91";"92";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"MDA-MB-415";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363633";"F";"SANGER: Inhibition of human SF539 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"SF-539";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363814";"F";"SANGER: Inhibition of human UACC-257 cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"UACC-257";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363343";"F";"SANGER: Inhibition of human KNS-81-FD cell growth in a cell viability assay.";"Homo sapiens";"137";"139";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"KNS-81-FD";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2363484";"F";"SANGER: Inhibition of human NCI-H1693 cell growth in a cell viability assay.";"Homo sapiens";"98";"99";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Sanger Institute Genomics of Drug Sensitivity in Cancer";"9606";"";"";"NCI-H1693";"";"CHEMBL1201861";"None";"10.6019/CHEMBL1201861";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562067";"F";"PubChem BioAssay. Immunotoxin (HA22) sensitization/mitigation study - treatment arm (low dose).   (Class of assay: confirmatory) ";"";"407";"409";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3595189";"B";"Inhibition of wild type GST-tagged FLT3 kinase domain (Y567 to S993) (unknown origin) expressed in baculovirus infected insect Sf9 cells using Her2 peptide as substrate after 4 hrs by Kinase-Glo assay";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"Sf9";"";"CHEMBL3593229";"26081023";"10.1016/j.ejmech.2015.05.008";"2015";"Eur J Med Chem";"100";"151";"161";"";"";"";"";"";""
"CHEMBL4401423";"B";"Binding affinity to human FLT3 ITD/D835V double mutant expressed in baculovirus expression system";"Homo sapiens";"7";"7";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4400537";"30742435";"10.1021/acs.jmedchem.8b01714";"2019";"J Med Chem";"62";"2428";"2446";"";"";"";"";"None";"UNDEFINED MUTATION"
"CHEMBL4303083";"F";"IC50 for antiviral activity against SARS-CoV-2 in the Vero E6 cell line at 48 h by immunofluorescence-based assay (detecting the viral NP protein in the nucleus of the Vero E6 cells).";"Chlorocebus sabaeus";"57";"57";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303773";"32353859";"10.1038/s41586-020-2286-9";"2020";"Nature";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4303086";"T";"Cytotoxicity of compound against Vero E6 cells by MTT assay.";"Chlorocebus sabaeus";"57";"57";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303773";"32353859";"10.1038/s41586-020-2286-9";"2020";"Nature";"None";"None";"None";"";"";"";"";"";""
